b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plospath" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2563037/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563037/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS Pathogens" /><meta name="citation_title" content="Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant" /><meta name="citation_authors" content="Noah S. Butler, Alex Theodossis, Andrew I. Webb, Roza Nastovska, Sri Harsha Ramarathinam, Michelle A. Dunstone, Jamie Rossjohn, Anthony W. Purcell, Stanley Perlman" /><meta name="citation_date" content="October 2008" /><meta name="citation_issue" content="10" /><meta name="citation_volume" content="4" /><meta name="citation_doi" content="10.1371/journal.ppat.1000186" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2563037/?report=abstract" /><meta name="citation_pmid" content="18949029" /><meta name="DC.Title" content="Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="Noah S. Butler" /><meta name="DC.Contributor" content="Alex Theodossis" /><meta name="DC.Contributor" content="Andrew I. Webb" /><meta name="DC.Contributor" content="Roza Nastovska" /><meta name="DC.Contributor" content="Sri Harsha Ramarathinam" /><meta name="DC.Contributor" content="Michelle A. Dunstone" /><meta name="DC.Contributor" content="Jamie Rossjohn" /><meta name="DC.Contributor" content="Anthony W. Purcell" /><meta name="DC.Contributor" content="Stanley Perlman" /><meta name="DC.Date" content="2008 Oct" /><meta name="DC.Identifier" content="10.1371/journal.ppat.1000186" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant" /><meta property="og:type" content="article" /><meta property="og:description" content="High affinity antigen-specific T cells play a critical role during protective immune responses. Epitope enhancement can elicit more potent T cell responses and can subsequently lead to a stronger memory pool; however, the molecular basis of such enhancement ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563037/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plospath.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2563037/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2563037/pdf/ppat.1000186.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A499BE99B05210000000002BE02BE.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/349/">PLoS Pathog</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/171924/">v.4(10); 2008 Oct</a></li><li class="accid">PMC2563037</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plospath.gif" alt="Logo of plospath" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS Pathogens" title="PLoS Pathogens" href="http://www.plospathogens.org/" ref="reftype=publisher&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plospathogens.org/static/checklist.action" ref="reftype=publisher&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plospathogens.org/static/contact.action" ref="reftype=publisher&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.ppat.1000186" ref="reftype=publisher&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS Pathog</span>. 2008 Oct; 4(10): e1000186. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Oct 24. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1371%2Fjournal.ppat.1000186" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.ppat.1000186</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2563037</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18949029">18949029</a></div></div></div></div><h1 class="content-title">Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Butler%20NS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029" class="affpopup" co-rid="_co_idm140686719865184" co-class="co-affbox">Noah S. Butler</a>,<sup>#</sup><sup>\n1\n,</sup><sup>\n2\n</sup> <a href="/pubmed/?term=Theodossis%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029" class="affpopup" co-rid="_co_idm140686719862448" co-class="co-affbox">Alex Theodossis</a>,<sup>#</sup><sup>\n3\n</sup> <a href="/pubmed/?term=Webb%20AI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029" class="affpopup" co-rid="_co_idm140686708171248" co-class="co-affbox">Andrew I. Webb</a>,<sup>\n4\n</sup> <a href="/pubmed/?term=Nastovska%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029" class="affpopup" co-rid="_co_idm140686709314560" co-class="co-affbox">Roza Nastovska</a>,<sup>\n4\n</sup> <a href="/pubmed/?term=Ramarathinam%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029" class="affpopup" co-rid="_co_idm140686709312192" co-class="co-affbox">Sri Harsha Ramarathinam</a>,<sup>\n4\n</sup> <a href="/pubmed/?term=Dunstone%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029" class="affpopup" co-rid="_co_idm140686723039888" co-class="co-affbox">Michelle A. Dunstone</a>,<sup>\n3\n</sup> <a href="/pubmed/?term=Rossjohn%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029" class="affpopup" co-rid="_co_idm140686723037520" co-class="co-affbox">Jamie Rossjohn</a>,<sup>\n3\n</sup> <a href="/pubmed/?term=Purcell%20AW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029" class="affpopup" co-rid="_co_idm140686719874384" co-class="co-affbox">Anthony W. Purcell</a>,<sup>\n4\n,</sup><sup>\n&#x0002a;\n</sup> and  <a href="/pubmed/?term=Perlman%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029" class="affpopup" co-rid="_co_idm140686707038240" co-class="co-affbox">Stanley Perlman</a><sup>\n1\n,</sup><sup>\n&#x0002a;\n</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140686719865184"><h3 class="no_margin">Noah S. Butler</h3><p>  <sup>1</sup>  Department of Microbiology, University of Iowa, Iowa City, Iowa, United States of America,   </p><p>  <sup>2</sup>  Immunology Graduate Program, University of Iowa, Iowa City, Iowa, United States of America,   </p><div>Find articles by <a href="/pubmed/?term=Butler%20NS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029">Noah S. Butler</a></div></div><div id="_co_idm140686719862448"><h3 class="no_margin">Alex Theodossis</h3><p>  <sup>3</sup>  The Protein Crystallography Unit, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria, Australia,   </p><div>Find articles by <a href="/pubmed/?term=Theodossis%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029">Alex Theodossis</a></div></div><div id="_co_idm140686708171248"><h3 class="no_margin">Andrew I. Webb</h3><p>  <sup>4</sup>  Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia,   </p><div>Find articles by <a href="/pubmed/?term=Webb%20AI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029">Andrew I. Webb</a></div></div><div id="_co_idm140686709314560"><h3 class="no_margin">Roza Nastovska</h3><p>  <sup>4</sup>  Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia,   </p><div>Find articles by <a href="/pubmed/?term=Nastovska%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029">Roza Nastovska</a></div></div><div id="_co_idm140686709312192"><h3 class="no_margin">Sri Harsha Ramarathinam</h3><p>  <sup>4</sup>  Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia,   </p><div>Find articles by <a href="/pubmed/?term=Ramarathinam%20SH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029">Sri Harsha Ramarathinam</a></div></div><div id="_co_idm140686723039888"><h3 class="no_margin">Michelle A. Dunstone</h3><p>  <sup>3</sup>  The Protein Crystallography Unit, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria, Australia,   </p><div>Find articles by <a href="/pubmed/?term=Dunstone%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029">Michelle A. Dunstone</a></div></div><div id="_co_idm140686723037520"><h3 class="no_margin">Jamie Rossjohn</h3><p>  <sup>3</sup>  The Protein Crystallography Unit, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria, Australia,   </p><div>Find articles by <a href="/pubmed/?term=Rossjohn%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029">Jamie Rossjohn</a></div></div><div id="_co_idm140686719874384"><h3 class="no_margin">Anthony W. Purcell</h3><p>  <sup>4</sup>  Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia,   </p><div>Find articles by <a href="/pubmed/?term=Purcell%20AW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029">Anthony W. Purcell</a></div></div><div id="_co_idm140686707038240"><h3 class="no_margin">Stanley Perlman</h3><p>  <sup>1</sup>  Department of Microbiology, University of Iowa, Iowa City, Iowa, United States of America,   </p><div>Find articles by <a href="/pubmed/?term=Perlman%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18949029">Stanley Perlman</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Michael J. Buchmeier, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140686722657664_ai idm140686719865312_ai idm140686706986592_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140686722657664_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140686722657664_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140686722657664_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  <sup>1</sup>  Department of Microbiology, University of Iowa, Iowa City, Iowa, United States of America,   </div><div class="fm-affl" lang="en" id="aff2">  <sup>2</sup>  Immunology Graduate Program, University of Iowa, Iowa City, Iowa, United States of America,   </div><div class="fm-affl" lang="en" id="aff3">  <sup>3</sup>  The Protein Crystallography Unit, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria, Australia,   </div><div class="fm-affl" lang="en" id="aff4">  <sup>4</sup>  Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia,   </div><div class="fm-affl" lang="en" id="edit1">University of California Irvine, United States of America</div><div><sup>#</sup>Contributed equally.</div><div id="cor1">&#x0002a; E-mail: <a href="mailto:dev@null" data-email="ua.ude.bleminu@llecrupa" class="oemail">ua.ude.bleminu@llecrupa</a> (AWP); <a href="mailto:dev@null" data-email="ude.awoiu@namlrep-yelnats" class="oemail">ude.awoiu@namlrep-yelnats</a> (SP)</div><div><p id="__p1" class="p p-first-last">Conceived and designed the experiments: NSB AT JR AWP SP. Performed the experiments: NSB AT AIW RN SHR MAD. Analyzed the data: NSB AT MAD JR AWP SP. Contributed reagents/materials/analysis tools: AIW. Wrote the paper: NSB AT JR AWP SP.</p></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140686722657664_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2008 Jul 28; Accepted 2008 Sep 24.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140686722657664_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> Butler et al.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2563037/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2>Associated Data</h2><dl data-count="5" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Figure S1: </strong>Immunogenicity of the Aba-modified, S598 peptidomimetic. (A) Intracellular IFN-&#x003b3; staining of splenocytes from mice peripherally immunized with JHMV simulated ex vivo with peptides (1 &#x000b5;M) corresponding to the native or Aba-modified S598 determinant. (B) Native S598 peptide is more stimulatory when S598-specific CTL are stimulated in the presence of reducing agent. Splenocytes were harvested from JHMV-immune mice and reacted with native S598 peptide (1 &#x000b5;M) in the presence of 500 &#x000b5;M TCEP. Data in A represent the mean&#x000b1;SEM for 3 experiments. Data in B are representative of five independent experiments.<p>(0.25 MB TIF)</p></div><div><a href="/pmc/articles/PMC2563037/bin/ppat.1000186.s001.tif" data-ga-action="click_feat_suppl">ppat.1000186.s001.tif</a><span style="color:gray"> (240K)</span></div><div class="small guid">GUID:\xc2\xa0D89093B7-6855-4B87-B984-A6580607E7C2</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Figure S2: </strong>TCR V&#x003b2; chain usage and alanine scanning analysis. (A) Total mononuclear cells were harvested from mice infected with rJ or rJ.S<sub>Q600Y</sub> and stimulated <em>ex vivo</em> with S598 and S598<sub>Q600Y</sub> peptides, respectively. Following stimulation, aliquots of cells were surface stained for CD8 and the indicated V&#x003b2; chain followed by intracellular cytokine staining for IFN-&#x003b3;. (B) CNS-derived cells from rJ.S<sub>Q600Y</sub>-infected mice were stimulated <em>ex vivo</em> with peptides corresponding to native S598 or S598<sub>Q600Y</sub> epitopes. Following stimulation, cells were analyzed as described for (A). Data represent the fraction of IFN-&#x003b3;&#x0002b;CD8&#x0002b; T cells expressing each V&#x003b2; chain and are derived from cells pooled from 2&#x02013;3 individual mice. (C) Alanine scanning of the native S598 determinant. CNS-derived mononuclear cells were recovered from rJ-infected mice 7 days p.i. and stimulated <em>ex vivo</em> in the presence of 500 &#x000b5;M TCEP and 1 &#x000b5;M of the indicated peptide then stained for CD8 and intracellular IFN-&#x003b3;. Data are normalized to the frequency of epitope-specific cells detected when stimulated with the native S598 determinant. (D) Alanine scanning of the S598<sub>Q600Y</sub> determinant. Cells were harvested and tested as described for B except in this case the cells originated from the rJ.S<sub>Q600Y</sub>-infected CNS and were stimulated with 10 nM S598<sub>Q600Y</sub> peptide. (E) Alanine scanning of the S598 determinant recognized by S598<sub>Q600Y</sub>-primed, cross-reactive CTL. As in C, but cells were stimulated with 150 nM S598 peptide. For B&#x02013;D, concentrations of peptide equivalent to 10&#x000d7; that required for half maximal stimulation were used; data are mean&#x000b1;SEM from four independent experiments. Note that the differential responses to RCAIFANI in panels C and D reflect the differing amounts of peptide used in the two assays.<p>(0.76 MB TIF)</p></div><div><a href="/pmc/articles/PMC2563037/bin/ppat.1000186.s002.tif" data-ga-action="click_feat_suppl">ppat.1000186.s002.tif</a><span style="color:gray"> (743K)</span></div><div class="small guid">GUID:\xc2\xa04984AC47-A303-456E-8364-5E74F0C48ED1</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Figure S3: </strong>Refined structures of WT and Q600Y S598-Aba bound to H-2K<sup>b</sup>. (A) View of the H-2K<sup>b</sup> antigen binding cleft from above. The HC is shown as a cartoon representation and coloured slate. The peptide is in stick format with carbon atoms coloured yellow. The unbiased <em>F<sub>o</sub>-F<sub>c</sub></em> map density for the peptide contoured at 2.5 &#x003c3; is shown as a magenta mesh. (B) The same view as in A displaying key interactions (dashed lines) between H-2K<sup>b</sup> and S598-Aba. Selected residues of the HC are drawn in stick format (slate carbon atoms) and ordered water molecules are shown as red spheres. Peptide residues are labelled in italics. C and D, Equivalencies to A and B, respectively, for the H-2K<sup>b</sup>/S598<sub>Q600Y</sub>-Aba structure. In these panels the HC is drawn in green and the peptide in cyan.<p>(4.07 MB EPS)</p></div><div><a href="/pmc/articles/PMC2563037/bin/ppat.1000186.s003.eps" data-ga-action="click_feat_suppl">ppat.1000186.s003.eps</a><span style="color:gray"> (3.8M)</span></div><div class="small guid">GUID:\xc2\xa0DD0BB7CB-B2AA-4C46-B6AE-18DA67F735A1</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Table S1: </strong>Data collection and refinement statistics.<p>(0.06 MB DOC)</p></div><div><a href="/pmc/articles/PMC2563037/bin/ppat.1000186.s004.doc" data-ga-action="click_feat_suppl">ppat.1000186.s004.doc</a><span style="color:gray"> (57K)</span></div><div class="small guid">GUID:\xc2\xa0130ABEC2-D887-4368-A4E3-852DE2D923FB</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Table S2: </strong>Contacts between the S598 determinant and H-2K<sup>b</sup>.<p>(0.07 MB DOC)</p></div><div><a href="/pmc/articles/PMC2563037/bin/ppat.1000186.s005.doc" data-ga-action="click_feat_suppl">ppat.1000186.s005.doc</a><span style="color:gray"> (65K)</span></div><div class="small guid">GUID:\xc2\xa03AB28404-FF2C-4FBB-91B0-217937BDCADB</div></div></dd></dl></div><div id="idm140686709533056" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140686709533056title">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first-last">High affinity antigen-specific T cells play a critical role during protective immune responses. Epitope enhancement can elicit more potent T cell responses and can subsequently lead to a stronger memory pool; however, the molecular basis of such enhancement is unclear. We used the consensus peptide-binding motif for the Major Histocompatibility Complex molecule H-2K<sup>b</sup> to design a heteroclitic version of the mouse hepatitis virus-specific subdominant S598 determinant. We demonstrate that a single amino acid substitution at a secondary anchor residue (Q to Y at position 3) increased the stability of the engineered determinant in complex with H-2K<sup>b</sup>. The structural basis for this enhanced stability was associated with local alterations in the pMHC conformation as a result of the Q to Y substitution. Recombinant viruses encoding this engineered determinant primed CTL responses that also reacted to the wildtype epitope with significantly higher functional avidity, and protected against selection of virus mutated at a second CTL determinant and consequent disease progression in persistently infected mice. Collectively, our findings provide a basis for the enhanced immunogenicity of an engineered determinant that will serve as a template for guiding the development of heteroclitic T cell determinants with applications in prevention of CTL escape in chronic viral infections as well as in tumor immunity.</p></div></div><div id="idm140686709530192" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140686709530192title">Author Summary</h2><!--article-meta--><div><p id="__p3" class="p p-first-last">Enhancing the immune responses to pathogens is a chief goal of vaccine development. Here, we describe the development of an engineered CD8&#x0002b; T cell epitope that elicits an immune response to the native epitope that is more potent than the one that occurs during the natural infection. We showed that this &#x0201c;improved&#x0201d; (heteroclitic) epitope protects against clinical disease and against cytotoxic T cell escape that frequently occurs in the immunodominant epitope expressed by the virus. We also performed structural analyses and showed that enhanced immunogenicity was associated with changes in the conformations of both the peptide and the region of the MHC class I molecule that is in close association with the peptide. These studies provide a model for designing T cell epitopes with enhanced immunogenicity that will be useful in vaccine development, with particular emphasis on diseases, such as HIV and hepatitis C, in which epitope mutation and escape is common.</p></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p id="__p4" class="p p-first">Despite the antigenic complexity of microbes, primary pathogen-specific cytotoxic CD8&#x0002b; T lymphocyte (CTL) responses are commonly directed to just one or a few determinants. Furthermore, even when multiple epitopes are targeted, distinct patterns of epitope hierarchy often emerge. Such immunodominant epitopes commonly elicit high-magnitude CTL responses characterized by potent cytolytic function, whereas subdominant determinants generate responses that are relatively lower in magnitude and often less efficacious. In general, potent anti-viral CTL strongly correlate with control of infection and less clinical disease. Viral progeny selected on the basis of CTL surveillance can evolve to evade T cell responses. This selective pressure results in mutations in immunodominant CTL determinants that abrogate recognition. CTL escape virus is commonly observed in humans and nonhuman primates infected with HIV-1, hepatitis C virus (HCV) or simian immunodeficiency virus (SIV) and its selection often correlates with disease progression <a href="#ppat.1000186-Bowen1" rid="ppat.1000186-Bowen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680498">[1]</a>&#x02013;<a href="#ppat.1000186-Oxenius1" rid="ppat.1000186-Oxenius1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680477">[4]</a>. Escape mutations may diminish binding to the restricting MHC class I molecule, interfere with T cell receptor (TcR) recognition or interfere with antigen processing <a href="#ppat.1000186-Draenert1" rid="ppat.1000186-Draenert1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680530">[5]</a>&#x02013;<a href="#ppat.1000186-Timm1" rid="ppat.1000186-Timm1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680524">[7]</a>. Escape mutations are usually detected in epitopes targeted by CTL that exhibit high functional avidity because the corresponding potent CTL response exerts high selective pressure on the virus <a href="#ppat.1000186-Goulder1" rid="ppat.1000186-Goulder1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680519">[2]</a>. In some HIV-infected patients, CTL escape occurs without an associated enhancement of virus replication, suggesting that the mutations compromised virus fitness or, alternatively, the variant determinant elicited a <em>de novo</em> CTL response <a href="#ppat.1000186-Allen1" rid="ppat.1000186-Allen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680507">[8]</a>,<a href="#ppat.1000186-Turnbull1" rid="ppat.1000186-Turnbull1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680474">[9]</a>. Virus fitness is sometimes restored, with concomitant increased virus replication, when a second, compensatory mutation is selected <a href="#ppat.1000186-Friedrich1" rid="ppat.1000186-Friedrich1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680476">[10]</a>,<a href="#ppat.1000186-Kelleher1" rid="ppat.1000186-Kelleher1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680481">[11]</a>. Collectively these results suggest that given the importance of virus diversification (CTL escape) in disease progression, suppression of selection or outgrowth of CTL escape variants should improve outcomes in persistently infected animals and humans.</p><p id="__p5">Modulating the immunogenicity of subdominant CTL determinants could potentially lead to the development of more efficacious vaccines that are more broadly protective and prevent or minimize the appearance of variant viruses that have mutated in dominant epitopes targeted by high-avidity CTL responses. Enhancement strategies, which result in augmented responses to the native, subdominant epitope, have been described for both MHC class I and class II-restricted determinants, whereby the most common approaches involve generating a series of conserved and non-conserved mutations at MHC anchor residues, followed by an empiric determination of whether each individual substitution augments T cell effector function <a href="#ppat.1000186-Purcell1" rid="ppat.1000186-Purcell1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680517">[12]</a>. Furthermore, evaluating the effect of epitope enhancement <em>in vivo</em> has generally been achieved via heterologous infection systems <a href="#ppat.1000186-Okazaki1" rid="ppat.1000186-Okazaki1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680522">[13]</a>&#x02013;<a href="#ppat.1000186-Tangri1" rid="ppat.1000186-Tangri1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680480">[15]</a>. Thus, while these results demonstrate proof of principle, direct evidence for enhanced protection against autologous microbial infection <em>in vivo</em> is lacking. The design of heteroclitic determinants in which non-MHC anchor residues are targeted for substitution are also usually determined empirically. Studies of heteroclitic tumor epitopes have demonstrated the clinical utility of such determinants <a href="#ppat.1000186-Dyall1" rid="ppat.1000186-Dyall1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680536">[16]</a>,<a href="#ppat.1000186-Fikes1" rid="ppat.1000186-Fikes1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680515">[17]</a>. Notably, however, there are no well defined examples of viral epitopes which demonstrate enhanced immunity and the molecular basis for the enhanced immunogenicity is not well understood.</p><p id="__p6">Potential interventions to directly manipulate host-pathogen interactions and thereby diminish CTL escape variant selection are often difficult to evaluate since most examples of CTL escape occur in infected humans or non-human primates. By contrast, mice persistently infected with mouse hepatitis virus (MHV) strain JHM (JHMV) serve as a useful system for investigating anti-viral CTL responses and CTL escape <a href="#ppat.1000186-Butler1" rid="ppat.1000186-Butler1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680495">[18]</a>&#x02013;<a href="#ppat.1000186-Pewe1" rid="ppat.1000186-Pewe1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680492">[20]</a>. Two JHMV-derived CTL epitopes are recognized in C57BL/6 (B6) mice. The immunodominant H-2D<sup>b</sup>-restricted CTL epitope (S510, CSLWNGPHL, spanning residues 510&#x02013;518 of the Spike (S) glycoprotein) elicits a high-magnitude, high-avidity CTL response that drives virus diversification during persistent infection <a href="#ppat.1000186-Butler1" rid="ppat.1000186-Butler1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680506">[18]</a>&#x02013;<a href="#ppat.1000186-Kim1" rid="ppat.1000186-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680493">[22]</a>. A second subdominant CTL epitope, S598 (H-2K<sup>b</sup>-restricted, RCQIFANI, spanning residues 598&#x02013;605 of the S glycoprotein) also elicits an appreciable CTL response <a href="#ppat.1000186-Castro1" rid="ppat.1000186-Castro1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680529">[21]</a>; however, S598-specific CTL exhibit &#x0223c;100-fold lower functional avidity and do not protect from CTL escape in S510. The presence of a readily mutable dominant and a subdominant epitope with high and low functional avidity, respectively, in JHMV-infected mice is useful for investigating both epitope enhancement and approaches to diminishing CTL escape. Consistent with this notion, we have previously shown that the introduction of a second dominant CD8 T cell epitope into the JHMV genome (GP33 from lymphocytic choriomeningitis virus (LCMV)) protected mice from the development of CTL escape in S510 and enhanced virus clearance <a href="#ppat.1000186-Kim1" rid="ppat.1000186-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680516">[22]</a>.</p><p id="__p7" class="p p-last">Here we determined whether the CD8 T cell response to S598 could be enhanced so that it now elicited a more potent T cell response that protected mice against the development of CTL escape at S510 and subsequent clinical disease. We modified epitope S598 (S598<sub>Q600Y</sub>) such that it elicited a high-avidity CTL response and using the crystal structures of the H-2K<sup>b</sup>/S598 and H-2K<sup>b</sup>/S598<sub>Q600Y</sub> complexes, determined the basis of this enhanced immune response. We then introduced this more immunogenic S598 epitope into a recombinant version of JHMV and showed that these high-avidity S598-specific CTLs protected against escape variants in the immunodominant S510 epitope. Immunization with the modified peptide resulted in an improved response to the native S598 epitope, demonstrating a true heteroclitic effect and suggesting that this strategy may have clinical applications for reducing viral titer and preventing CTL escape during chronic infections.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Results</h2><div id="s2a" class="sec sec-first"><h3 id="s2atitle">Induction of protective T cell responses with a heteroclitic virus</h3><p id="__p8" class="p p-first">As we have previously observed with other MHC/Cys-containing peptide complexes <a href="#ppat.1000186-Butler2" rid="ppat.1000186-Butler2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680513">[19]</a>,<a href="#ppat.1000186-Webb1" rid="ppat.1000186-Webb1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680496">[23]</a>, complexes did not readily form unless the cysteine of the S598 peptide (R<span class="underline">C</span>QIFANI) was modified with L-&#x003b1;-aminobutyric acid (Aba, an isostereomer of cysteine). The Aba-modified peptides maintained immunogenicity since a higher frequency of splenic CD8&#x0002b; T cells from JHMV-immune mice reacted to Aba-modified S598 peptide, relative to unmodified S598 peptide (<a href="#ppat.1000186.s001" rid="ppat.1000186.s001" class=" supplementary-material">\n<strong>Figure S1A</strong>\n</a>).</p><p id="__p9">Next, we used the consensus H-2K<sup>b</sup> binding motif <a href="#ppat.1000186-Falk1" rid="ppat.1000186-Falk1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680528">[24]</a> to engineer a novel, high-avidity S598 CTL epitope. Importantly, Gln-3 diverges from the consensus H-2K<sup>b</sup>-restricted ligand binding motif, in which a tyrosine is often present at position 3 <a href="#ppat.1000186-Falk1" rid="ppat.1000186-Falk1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680486">[24]</a>,<a href="#ppat.1000186-vanBleek1" rid="ppat.1000186-vanBleek1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680509">[25]</a>. Therefore, we substituted a glutamine residue for tyrosine (Q600Y, CAA to TAT, RC<span class="underline">Y</span>IFANI) at position 3 of the determinant with the aim of creating a peptide that bound more tightly to H-2K<sup>b</sup>. Stability of the H-2K<sup>b</sup>/S598 and H-2K<sup>b</sup>/S598<sub>Q600Y</sub> complexes was assessed by circular dichroism (CD). As shown in <a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g001" rid-ob="ob-ppat-1000186-g001" co-legend-rid="lgnd_ppat-1000186-g001"><span>\n<strong>Figure 1</strong>\n</span></a>, H-2K<sup>b</sup>/S598<sub>Q600Y</sub> was considerably more thermostable than the native complex (Tm 54&#x000b0;C vs 64&#x000b0;C). To probe the biological properties of the Q600Y substitution, we used reverse genetics to engineer a recombinant version of JHMV expressing the S598<sub>Q600Y</sub> epitope (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g002" rid-ob="ob-ppat-1000186-g002" co-legend-rid="lgnd_ppat-1000186-g002"><span>\n<strong>Figure 2A</strong>\n</span></a>). Recombinant viruses encoding this substitution replicated as efficiently as wild type JHMV (rJ) <em>in vitro</em> during one-step growth kinetics analyses and <em>in vivo</em> virus competition assays (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g002" rid-ob="ob-ppat-1000186-g002" co-legend-rid="lgnd_ppat-1000186-g002"><span>\n<strong>Figure 2B, C</strong>\n</span></a>). The immunogenicity of S598<sub>Q600Y</sub> was assessed by intracellular expression of IFN-&#x003b3; by central nervous system (CNS)-derived lymphocytes. Since Cys-containing peptides are often diminished in ability to elicit a CTL response, we included a reducing agent (TCEP, Tris[2-carboxyethyl] phosphine) in the cultures. TCEP enhanced the stimulatory capacity of the S598 peptides (<a href="#ppat.1000186.s001" rid="ppat.1000186.s001" class=" supplementary-material">\n<strong>Figure S1B</strong>\n</a>), indicating that a proportion of the unmodified S598 peptide stock had undergone oxidation. Thus, we stimulated CNS- and spleen-derived CTL <em>ex vivo</em> in the presence of 500 &#x000b5;M TCEP, a concentration consistent with other work with Cys containing peptides <a href="#ppat.1000186-Webb1" rid="ppat.1000186-Webb1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680514">[23]</a>,<a href="#ppat.1000186-Mannering1" rid="ppat.1000186-Mannering1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680491">[26]</a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="ppat-1000186-g001" co-legend-rid="lgnd_ppat-1000186-g001"><a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g001/" target="figure" rid-figpopup="ppat-1000186-g001" rid-ob="ob-ppat-1000186-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140686721783152" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2563037_ppat.1000186.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is ppat.1000186.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2563037/bin/ppat.1000186.g001.jpg" /></a></div><div id="largeobj_idm140686721783152" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_ppat-1000186-g001"><div><a class="figpopup" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g001/" target="figure" rid-figpopup="ppat-1000186-g001" rid-ob="ob-ppat-1000186-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Thermal stability of the S598 and S598<sub>Q600Y</sub> epitopes in complex with H-2K<sup>b</sup>.</strong><p id="__p10">Circular dichroism (CD) analysis of S598-Aba (dashed line), S510-Aba (variable dash line) and S598<sub>Q600Y</sub>-Aba (solid line) complexed with H-2K<sup>b</sup>. CD spectra were measured as described in <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="ppat-1000186-g002" co-legend-rid="lgnd_ppat-1000186-g002"><a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g002/" target="figure" rid-figpopup="ppat-1000186-g002" rid-ob="ob-ppat-1000186-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140686791039680" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2563037_ppat.1000186.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is ppat.1000186.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2563037/bin/ppat.1000186.g002.jpg" /></a></div><div id="largeobj_idm140686791039680" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_ppat-1000186-g002"><div><a class="figpopup" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g002/" target="figure" rid-figpopup="ppat-1000186-g002" rid-ob="ob-ppat-1000186-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Fitness of and CTL responses elicited by rJ and rJ.S<sub>Q600Y</sub>.</strong><p id="__p11">(A) Schematic depictions of recombinant wild type JHMV (rJ), recombinant JHMV encoding the Q600Y substitution (rJ.S<sub>Q600Y</sub>) and recombinant JHMV encoding the S598<sub>Q600Y</sub> substitution in the context of an S510 CTL escape mutation (S510<sub>W513R&#x0002b;Q600Y</sub>). (B) Equivalent <em>in vitro</em> growth kinetics among rJ and rJ.S<sub>Q600Y</sub> viruses. 17Cl-1 cells were infected with rJ or rJ.S<sub>Q600Y</sub> at a multiplicity of infection (MOI) of 1.0. Cells and supernatants were harvested at the indicated times and titers were measured by plaque assay as described in <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>. Data are representative of two independent experiments. (C) Equivalent <em>in vivo</em> fitness among rJ and rJ.S<sub>Q600Y</sub> viruses. Five week old B6 and BALB/c mice were infected with virus mixtures consisting of equal PFU of rJ and rJ.S<sub>Q600Y</sub> variant virus. Seven days p.i., total RNA was harvested from the brains of mice and relative representation of virus template was determined via RT-PCR and direct sequencing of PCR products. The relative proportion of animals in which only rJ, only rJ.S<sub>Q600Y</sub>, or a mixture of the two viruses is shown. (D) High-magnitude, unidirectional cross-reactivity. Representative dot plots demonstrating the frequency of epitope-specific CD8 T cells in a mouse infected with rJ (top panels) or rJ.S<sub>Q600Y</sub> (bottom panels). Numbers represent the frequency of epitope-specific CD8 T cells among total CD8 T cells recovered from the brains of mice 7 days p.i. (E) Summaries of the frequency (left panel) and absolute number (right panel) of epitope-specific CD8 T cells recovered from the brains of rJ and rJ.S<sub>Q600Y</sub>-infected mice 7 days p.i. Data shown in D represent mean&#x000b1;SEM for 4 independent experiments.</p></div></div></div><p id="__p12">The S598<sub>Q600Y</sub> epitope elicited a CTL response in the CNS of rJ.S<sub>Q600Y</sub> infected mice, with nearly 30&#x00025; of all CD8 T cells recognizing the determinant (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g002" rid-ob="ob-ppat-1000186-g002" co-legend-rid="lgnd_ppat-1000186-g002"><span>\n<strong>Figure 2D</strong>\n</span></a>). In addition, CTL primed by S598<sub>Q600Y</sub> cross-reacted with the native S598 determinant. The converse was not true, however, as cells primed by the native epitope failed to produce IFN-&#x003b3; when stimulated with S598<sub>Q600Y</sub> peptide (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g002" rid-ob="ob-ppat-1000186-g002" co-legend-rid="lgnd_ppat-1000186-g002"><span>\n<strong>Figure 2D</strong>\n</span></a>). Of note, the CTL response to the dominant D<sup>b</sup>-restricted S510 epitope in rJ.S<sub>Q600Y</sub>-infected mice was diminished relative to responses in mice infected with wildtype rJ virus (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g002" rid-ob="ob-ppat-1000186-g002" co-legend-rid="lgnd_ppat-1000186-g002"><span>\n<strong>Figure 2D, E</strong>\n</span></a>).</p><p id="__p13">Next, we assessed the relative functional avidity of CTL populations primed by native S598 and S598<sub>Q600Y</sub> determinants, as a surrogate measure of the potency of the anti-virus CTL response <em>in vivo</em>. CNS-derived mononuclear cells were harvested from mice infected with rJ or rJ.S<sub>Q600Y</sub> and examined for IFN-&#x003b3; expression after stimulation <em>ex vivo</em> in the presence of 10-fold dilutions of the appropriate peptide. Cells primed to the native S598 epitope (cells harvested from rJ-infected mice) required approximately 100-fold more peptide than did S598<sub>Q600Y</sub>-primed cells to elicit a half maximal response (100 nM vs. 1 nM, <a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003" co-legend-rid="lgnd_ppat-1000186-g003"><span>\n<strong>Figure 3A,B</strong>\n</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="ppat-1000186-g003" co-legend-rid="lgnd_ppat-1000186-g003"><a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140686717760000" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2563037_ppat.1000186.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is ppat.1000186.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2563037/bin/ppat.1000186.g003.jpg" /></a></div><div id="largeobj_idm140686717760000" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_ppat-1000186-g003"><div><a class="figpopup" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>S598<sub>Q600Y</sub> elicits a CTL response with higher functional avidity than wild type S598, protects from clinical disease in the context of an S510 CTL escape mutation and enhances virus clearance.</strong><p id="__p14">(A) Functional avidity analysis of CD8 T cell populations primed by native S598 determinant or modified S598<sub>Q600Y</sub> determinant. Five week old B6 mice were infected with rJ or rJ.S<sub>Q600Y</sub> variant virus. Seven days p.i., CNS-derived mononuclear cells were harvested and cell aliquots were stimulated <em>ex vivo</em> with 10-fold serial dilutions of the native S598 peptide (for rJ-infected) or S598<sub>Q600Y</sub> peptide (for rJ.S<sub>Q600Y</sub>-infected). Data are normalized to the frequency of determinant-specific cells detected using 1 &#x000b5;M of peptide. (B) Concentration of peptide required to elicit a half-maximal response during <em>ex vivo</em> cell stimulation. (C) Functional avidity of cross-reactive S598<sub>Q600Y</sub>-primed CTL. Five week old B6 mice were infected with rJ or rJ.S<sub>Q600Y</sub>, CNS-derived mononuclear cells were harvested and cell aliquots were stimulated <em>ex vivo</em> in the presence of 500 &#x000b5;M TCEP with 10-fold serial dilutions of only the native S598 peptide. Data are normalized to the frequency of determinant-specific cells detected using 1 &#x000b5;M of peptide. (D) Concentration of peptide required to elicit a half-maximal response during <em>ex vivo</em> cell stimulation. Data for A&#x02013;D represent mean&#x000b1;SEM for 4 independent experiments. (E) Survival analysis of maternal antibody-protected suckling mice infected with rJ or rJ.S<sub>Q600Y</sub> variant viruses. Suckling mice were infected at 10 days of age and nursed on dams that had been previously immunized with virulent JHMV. To control for the delivery of protective maternal antibody, one-half of each litter was infected with rJ while the other half was infected with rJ.S<sub>Q600Y</sub>. Data represent results from 10 litters derived from multiple independent JHMV-immune dams. Numbers in parentheses indicate the number of pups infected with each virus. Mice surviving the acute infection (day 0&#x02013;14 p.i.) were monitored to day 60 p.i. and scored as deceased following development of hind limb paralysis/paresis. (F) Frequency of epitope-specific CD8 T cells in the brain of an rJ.S<sub>W513R&#x0002b;Q600Y</sub>-infected mouse. Seven days p.i., CNS-derived mononuclear cells were harvested, stimulated <em>ex vivo</em> with the indicated peptides and stained for CD8 and intracellular IFN-&#x003b3; as described in <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>. The frequency of cells that produced IFN-&#x003b3; in response to an irrelevant peptide (OVA (chicken ovalbumen, not shown) was equivalent to the S510-specific response. (G) Survival analysis of suckling mice infected with rJ, rJ.S<sub>W513R</sub> or rJ.S<sub>W513R&#x0002b;Q600Y</sub>. One-third of the pups in an individual litter were infected with each virus. Data represent results from 6 litters derived from multiple independent JHMV-immune dams. Numbers in parentheses indicate the number of pups infected with each virus. Mice surviving the acute infection (day 0&#x02013;14 p.i.) were monitored to day 60 p.i. and scored as deceased following development of hind limb paralysis/paresis. (H) Virus titers in the brains of maternal antibody-protected suckling mice 5 or 6 days following infection with rJ, rJ.S<sub>Q600Y</sub>, rJ.S<sub>W513R</sub> or rJ.S<sub>W513R&#x0002b;Q600Y</sub> viruses. One-fourth of the pups in an individual litter were infected with each virus. At the indicated day p.i., brains were aseptically harvested, homogenized in sterile PBS and clarified by centrifugation. Supernatants were collected and infectious virus was titered on Hela-MHVR (Hela cells transfected with CEACAM1, the JHMV receptor <a href="#ppat.1000186-Williams1" rid="ppat.1000186-Williams1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680497">[59]</a>) as previously described <a href="#ppat.1000186-Perlman1" rid="ppat.1000186-Perlman1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_850014201">[27]</a>. Symbols on graph represent individual mice assayed from multiple independent litters. The limit of detection (LOD) for the assay is 80 PFU/brain. Nonpaired, two-sided Student\'s <em>t</em> tests were used for statistical analyses.</p></div></div></div><p id="__p15">Because we observed that a subpopulation of S598<sub>Q600Y</sub>-primed cells cross-reacted with the native determinant, we next determined whether this subpopulation also exhibited high functional avidity. For this purpose, we isolated cells from the CNS of rJ- and rJ.S<sub>Q600Y</sub>-infected adult B6 mice and stimulated them with 10-fold dilutions of native S598 peptide. S598<sub>Q600Y</sub>-primed cross-reacting cells exhibited 7-fold higher functional avidity, relative to those primed by the native determinant (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003" co-legend-rid="lgnd_ppat-1000186-g003"><span>\n<strong>Figure 3C, D</strong>\n</span></a>) and are therefore distinct from CTL primed by the native S598 determinant. Consistent with the presence of a distinct population of cells, there were modest differences in V&#x003b2; chain utilization when total populations from rJ and rJ.S<sub>Q600Y</sub>-infected mice and when total and cross-reacting cell populations from rJ.S<sub>Q600Y</sub>-infected mice (<a href="#ppat.1000186.s002" rid="ppat.1000186.s002" class=" supplementary-material">\n<strong>Figure S2</strong>\n</a>) were compared. In all instances, V&#x003b2;5.1/5.2 expression was relatively over-represented, but some V&#x003b2; elements were preferentially utilized by specific responding populations (V&#x003b2;11, V&#x003b2;13 and V&#x003b2;14). Also consistent with this observation, alanine scanning mutagenesis of the two determinants revealed that the CTL response to each cognate peptide following infection was also subtly different reflecting the altered repertoire. The CTL response to each cognate peptide was very sensitive to mutation at every position except 2 and 9 although mutations in the S598<sub>Q600Y</sub> determinant were tolerated slightly better than changes in the S598 epitope (<a href="#ppat.1000186.s002" rid="ppat.1000186.s002" class=" supplementary-material">\n<strong>Figure S2C&#x02013;E</strong>\n</a>).</p><p id="__p16" class="p">If CTL recognizing S598<sub>Q600Y</sub> exhibit high functional avidity <em>in vivo</em>, they should protect from CTL escape in S510 and might select for S598<sub>Q600Y</sub> CTL escape variants. Diversification at S510 is observed in pups infected with neurovirulent JHMV at 10 days of age and nursed by JHMV-immune dams <a href="#ppat.1000186-Perlman1" rid="ppat.1000186-Perlman1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_850014203">[27]</a>. These mice are largely protected from developing acute lethal encephalitis, but a variable percentage (30&#x02013;90&#x00025;) later develop a demyelinating encephalomyelitis. Infectious virus isolated from these mice with late onset clinical disease is mutated in S510, resulting in enhanced virus replication <a href="#ppat.1000186-Pewe1" rid="ppat.1000186-Pewe1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680510">[20]</a>, with demyelination occurring during the process of virus clearance <a href="#ppat.1000186-Wu1" rid="ppat.1000186-Wu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680483">[28]</a>. Thus, we next infected maternal antibody-protected suckling mice with rJ or rJ.S<sub>Q600Y</sub> viruses and monitored persistently infected mice for the development of clinical signs for 60 days post infection (p.i.). The presence of the highly immunogenic S598<sub>Q600Y</sub> epitope did not protect mice from acute encephalitis (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003" co-legend-rid="lgnd_ppat-1000186-g003"><span>\n<strong>Figure 3E</strong>\n</span></a>), perhaps because the presence of the improved S598 epitope was accompanied by a diminished response to S510 (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g002" rid-ob="ob-ppat-1000186-g002" co-legend-rid="lgnd_ppat-1000186-g002"><span>\n<strong>Figure 2D</strong>\n</span></a>). However, we found that among survivors (defined as survival past day 14 p.i.) there was a significant reduction in the incidence of clinical disease as well as in the development of CTL escape in S510 (<a href="/pmc/articles/PMC2563037/table/ppat-1000186-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-t001" rid-ob="ob-ppat-1000186-t001" co-legend-rid=""><span>\n<strong>Table 1</strong>\n</span></a>). Additionally, S598<sub>Q600Y</sub> did not undergo CTL escape in mice persistently infected with rJ.S<sub>Q600Y</sub>, even though single nucleotide changes in the region of the S glycoprotein gene encoding the S598 determinant could potentially result in fifty-one CTL escape mutations. Thus, as expected, the &#x0201c;improved&#x0201d; S598<sub>Q600Y</sub> epitope was protective <em>in vivo</em> in infected mice, likely because S598<sub>Q600Y</sub>-specific CTL are present in higher numbers and exhibit higher functional avidity than the native S598-specific response.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="ppat-1000186-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Incidence of clinical disease and development of CTL escape in rJ and rJ.S<sub>Q600Y</sub> infected mice.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140686708576912" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Index Virus (survivors)<sup>a</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x00025; Clinical Disease<sup>b</sup>\n</td><td align="left" rowspan="1" colspan="1">S510 Escape Symptomatic<sup>c</sup>\n</td><td align="left" rowspan="1" colspan="1">S510 Escape Asymptomatic<sup>c</sup>\n</td><td align="left" rowspan="1" colspan="1">S598 Escape: (symptomatic and asymptomatic)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">rJ (n&#x0200a;=&#x0200a;19)</td><td align="left" rowspan="1" colspan="1">58 (11/19)</td><td align="left" rowspan="1" colspan="1">10/11</td><td align="left" rowspan="1" colspan="1">8/8</td><td align="left" rowspan="1" colspan="1">0/19</td></tr><tr><td align="left" rowspan="1" colspan="1">rJ.S<sub>Q600Y</sub> (n&#x0200a;=&#x0200a;19)</td><td align="left" rowspan="1" colspan="1">21 (4/19)<sup>a</sup>\n</td><td align="left" rowspan="1" colspan="1">0/4</td><td align="left" rowspan="1" colspan="1">0/15</td><td align="left" rowspan="1" colspan="1">0/19</td></tr></tbody></table></div><div id="largeobj_idm140686708576912" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2563037/table/ppat-1000186-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt101"><sup>a</sup>Numbers that survived acute infection (days 0&#x02013;14 p.i.).</div><div id="nt102"><sup>b</sup>&#x003c7;<sup>2</sup>&#x0200a;=&#x0200a;5.39, <em>P</em>&#x0003c;0.025 for rJ versus rJ.S<sub>Q600Y</sub>.</div><div id="nt103"><sup>c</sup>&#x003c7;<sup>2</sup>&#x0200a;=&#x0200a;32, <em>P</em>&#x0003c;0.0001 for rJ versus rJ.S<sub>Q600Y</sub>.</div></div></div></div><div id="s2b" class="sec"><h3 id="s2btitle">S598<sub>Q600Y</sub>-specific CTL are protective in mice infected with S510 CTL escape virus</h3><p id="__p20" class="p p-first">Since this lack of mutation at S598<sub>Q600Y</sub> might reflect enhanced suppression of virus replication mediated by co-dominant CTL responses directed against S510 and S598<sub>Q600Y</sub>, we developed a recombinant virus encoding S598<sub>Q600Y</sub> in the context of a common S510 CTL escape mutation, S510<sub>W513R</sub> (<strong>rJ.S<sub>W513R&#x0002b;Q600Y</sub>, </strong>\n<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g002" rid-ob="ob-ppat-1000186-g002" co-legend-rid="lgnd_ppat-1000186-g002"><span>\n<strong>Figure 2A</strong>\n</span></a>). The CTL response is predicted to be largely directed at S598<sub>Q600Y</sub> in mice infected with this virus. The W513R mutation (position 4 substitution in S510 epitope, CSL<span class="underline">R</span>NGPHL) occurs in 13&#x00025; of all CTL escape variants <a href="#ppat.1000186-Butler2" rid="ppat.1000186-Butler2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680512">[19]</a>,<a href="#ppat.1000186-Pewe1" rid="ppat.1000186-Pewe1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680472">[20]</a>,<a href="#ppat.1000186-Kim1" rid="ppat.1000186-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680511">[22]</a>,<a href="#ppat.1000186-Dandekar1" rid="ppat.1000186-Dandekar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680518">[29]</a>,<a href="#ppat.1000186-Pewe2" rid="ppat.1000186-Pewe2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680504">[30]</a>, and completely abrogates native S510 CTL recognition <a href="#ppat.1000186-Pewe3" rid="ppat.1000186-Pewe3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680500">[31]</a>. We verified that virus-specific CTL responses were focused on S598<sub>Q600Y</sub> in adult B6 mice infected with rJ.S<sub>W513R&#x0002b;Q600Y</sub> (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003" co-legend-rid="lgnd_ppat-1000186-g003"><span>\n<strong>Figure 3F</strong>\n</span></a>). To examine the phenotype of the S598<sub>Q600Y</sub>/S510<sub>W513R</sub> double mutant, we infected antibody-protected suckling B6 mice with this virus and appropriate controls and monitored mice for survival (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003" co-legend-rid="lgnd_ppat-1000186-g003"><span>\n<strong>Figure 3G</strong>\n</span></a>). As expected, 93.3&#x00025; of mice infected with rJ survived the acute infection (day 0&#x02013;14 p.i.). All mice infected with rJ.S<sub>W513R</sub> developed fatal encephalitis but, in marked contrast, 66.6&#x00025; of mice infected with rJ.S<sub>W513R&#x0002b;Q600Y</sub> survived. We also found that survival correlated with virus clearance (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003" co-legend-rid="lgnd_ppat-1000186-g003"><span>\n<strong>Figure 3H</strong>\n</span></a>). Relative to rJ-infected mice, replication was suppressed in mice infected with virus encoding the S598<sub>Q600Y</sub> epitope and greatly elevated in mice infected with rJ.S<sub>W513R</sub>. In mice infected with rJ.S<sub>W513R&#x0002b;Q600Y</sub>, virus titers were intermediate between rJ and rJ.S<sub>W513R</sub>. Thus, the presence of the heteroclitic S598<sub>Q600Y</sub> determinant contributed to suppression of virus replication and to increased survival, even when the high-magnitude, high-avidity CTL response to S510 was largely abrogated.</p><p id="__p21" class="p">Surprisingly, S598<sub>Q600Y</sub> still did not undergo sequence diversification in mice that survived the rJ.S<sub>W513R&#x0002b;Q600Y</sub> infection (<a href="/pmc/articles/PMC2563037/table/ppat-1000186-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-t002" rid-ob="ob-ppat-1000186-t002" co-legend-rid=""><span>\n<strong>Table 2</strong>\n</span></a>). This result was unexpected, as the majority of CTL in the rJ.S<sub>W513R&#x0002b;Q600Y</sub>-infected CNS specifically target the S598<sub>Q600Y</sub> determinant and exhibit high functional avidity (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003" co-legend-rid="lgnd_ppat-1000186-g003"><span>\n<strong>Figure 3A&#x02013;C</strong>\n</span></a>). One possible explanation for this result is that S598 is not as plastic as S510, even though both determinants are derived from a region of the spike gene that is hypervariable and even deleted in some strains of MHV <a href="#ppat.1000186-Weiss1" rid="ppat.1000186-Weiss1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680523">[32]</a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="ppat-1000186-t002"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Incidence of clinical disease and CTL escape in rJ and rJ.S<sub>W513R&#x0002b;Q600Y</sub> infected mice.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140686720559232" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Index Virus (survivors)<sup>a</sup>\n</td><td align="left" rowspan="1" colspan="1">&#x00025; Clinical Disease<sup>b</sup>\n</td><td align="left" rowspan="1" colspan="1">S510 Escape Symptomatic<sup>c</sup>\n</td><td align="left" rowspan="1" colspan="1">S510 Escape Asymptomatic<sup>c</sup>\n</td><td align="left" rowspan="1" colspan="1">S598 Escape: (symptomatic and asymptomatic)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">rJ (n&#x0200a;=&#x0200a;14)</td><td align="left" rowspan="1" colspan="1">43 (6/14)</td><td align="left" rowspan="1" colspan="1">5/6</td><td align="left" rowspan="1" colspan="1">3/8</td><td align="left" rowspan="1" colspan="1">0/14</td></tr><tr><td align="left" rowspan="1" colspan="1">rJ.S<sub>W513R&#x0002b;Q600Y</sub> (n&#x0200a;=&#x0200a;10)</td><td align="left" rowspan="1" colspan="1">60 (6/10)</td><td align="left" rowspan="1" colspan="1">0/6</td><td align="left" rowspan="1" colspan="1">0/4</td><td align="left" rowspan="1" colspan="1">0/10</td></tr></tbody></table></div><div id="largeobj_idm140686720559232" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2563037/table/ppat-1000186-t002/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt104"><sup>a</sup>Numbers that survived acute infection (days 0&#x02013;14 p.i.).</div><div id="nt105"><sup>b</sup>&#x003c7;<sup>2</sup>&#x0200a;=&#x0200a;1.50, <em>P</em>&#x0200a;=&#x0200a;0.221 for rJ versus rJ.S<sub>W513R&#x0002b;Q600Y</sub>.</div><div id="nt106"><sup>c</sup>&#x003c7;<sup>2</sup>&#x0200a;=&#x0200a;8.57. <em>P</em>&#x0200a;=&#x0200a;0.0034 for epitope S510 CTL escape in rJ versus rJ.S<sub>W513R&#x0002b;Q600Y</sub>.</div></div></div></div><div id="s2c" class="sec"><h3 id="s2ctitle">Enhanced recognition of S598 by cells primed to S598<sub>Q600Y</sub>\n</h3><p id="__p25" class="p p-first">To determine whether cells primed to S598<sub>Q600Y</sub> that cross-react with the native S598 determinant were more protective <em>in vivo</em> than S598-primed cells, we vaccinated mice with bone marrow-derived dendritic cells (BMDC) alone, or BMDC pulsed with peptides corresponding to S598 or S598<sub>Q600Y</sub> (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g004" rid-ob="ob-ppat-1000186-g004" co-legend-rid="lgnd_ppat-1000186-g004"><span>\n<strong>Figure 4</strong>\n</span></a>). Seven days later, mice were challenged via intranasal inoculation of 4&#x000d7;10<sup>4</sup> PFU of wild type, non-recombinant JHMV. Similar to results observed following rJ.S<sub>Q600Y</sub> infection (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003" co-legend-rid="lgnd_ppat-1000186-g003"><span>\n<strong>Figure 3</strong>\n</span></a>), CTL primed via DC-S598<sub>Q600Y</sub> vaccination exhibited higher functional avidity when reacted against the native S598 determinant when compared to those arising after DC-S598 vaccination <strong>(</strong>\n<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g004" rid-ob="ob-ppat-1000186-g004" co-legend-rid="lgnd_ppat-1000186-g004"><span>\n<strong>Figure 4A</strong>\n</span></a>\n<strong>)</strong>. In other experiments, we examined the survival of mice vaccinated with each determinant, but we observed no significant differences between groups (data not shown), probably because mortality is largely CD4 T cell-mediated in adult mice with acute encephalitis <a href="#ppat.1000186-Anghelina1" rid="ppat.1000186-Anghelina1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680479">[33]</a>,<a href="#ppat.1000186-Stohlman1" rid="ppat.1000186-Stohlman1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_628026569">[34]</a>. In terms of virus titers, vaccination with either the native or enhanced S598 determinants resulted in &#x0223c;70&#x02013;80&#x00025; reduction in virus burden compared to mice that received un-pulsed BMDC (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g004" rid-ob="ob-ppat-1000186-g004" co-legend-rid="lgnd_ppat-1000186-g004"><span>\n<strong>Figure 4B</strong>\n</span></a>). When we examined the frequency and numbers of virus-specific CTL in the CNS of these same mice, we detected markedly fewer S598-specific CTL in the CNS of mice that received BMDC pulsed with S598<sub>Q600Y</sub> peptides (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g004" rid-ob="ob-ppat-1000186-g004" co-legend-rid="lgnd_ppat-1000186-g004"><span>\n<strong>Figure 4C</strong>\n</span></a>). Calculation of the product of virus titers and CTL numbers within individual mice, as an approximate measure of CTL potency, indicated that the S598-specific CTL in S598<sub>Q600Y</sub>-coated BMDC vaccinees were &#x0223c;6-7-fold more efficacious on a per cell basis (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g004" rid-ob="ob-ppat-1000186-g004" co-legend-rid="lgnd_ppat-1000186-g004"><span>\n<strong>Figure 4D</strong>\n</span></a>). Thus, S598-specific CTL induced by the S598<sub>Q600Y</sub> determinant show similar enhancement in function compared to S598-primed cells, whether measured <em>in vitro</em> (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g003" rid-ob="ob-ppat-1000186-g003" co-legend-rid="lgnd_ppat-1000186-g003"><span>\n<strong>Figure 3C,D</strong>\n</span></a>) or <em>in vivo</em> (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g004" rid-ob="ob-ppat-1000186-g004" co-legend-rid="lgnd_ppat-1000186-g004"><span>\n<strong>Figure 4D</strong>\n</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="ppat-1000186-g004" co-legend-rid="lgnd_ppat-1000186-g004"><a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g004/" target="figure" rid-figpopup="ppat-1000186-g004" rid-ob="ob-ppat-1000186-g004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140686721540784" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2563037_ppat.1000186.g004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is ppat.1000186.g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2563037/bin/ppat.1000186.g004.jpg" /></a></div><div id="largeobj_idm140686721540784" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_ppat-1000186-g004"><div><a class="figpopup" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g004/" target="figure" rid-figpopup="ppat-1000186-g004" rid-ob="ob-ppat-1000186-g004">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Functional avidity and protective capacity of cross-reactive, S598<sub>Q600Y</sub>-primed CTL.</strong><p id="__p26">(A) Functional avidity analyses of S598- and S598<sub>Q600Y</sub>-primed CTL. Groups of 4-week-old B6 mice were vaccinated with LPS-matured bone marrow-derived DC pulsed with peptides corresponding to S598<sub>Q600Y</sub>, native S598 or no peptide. Seven days following DC vaccination, mice were intranasally infected with 8&#x000d7;10<sup>4</sup> PFU of non-recombinant JHMV. On day 7 p.i., CNS-derived mononuclear cells were stimulated <em>ex vivo</em> with 10-fold serial dilutions of native S598 peptide. Data are normalized to the frequency of S598-specific cells detected using 1 &#x000b5;M of peptide. Data represent mean&#x000b1;SEM for 3 independent experiments. (B&#x02013;D) Virus titers and magnitude of CTL response. Brains were aseptically removed from individual DC-vaccinated mice 7 days following JHMV challenge. One-half of the brain was homogenized and clarified for viral titer determination (B) while the other half was used to determine the numbers of S598-specific CTL (C). The relative efficacy of S598-specific CTL (D) was derived by calculating the product of virus titers and absolute numbers of S598-specific CTL for each individual mouse. Data in B&#x02013;D represent results from six individual mice analyzed in two independent experiments.</p></div></div></div></div><div id="s2d" class="sec sec-last"><h3 id="s2dtitle">Structures of the wild-type and engineered S598 H2K<sup>b</sup> complexes</h3><p id="__p27" class="p p-first">While these studies clearly demonstrated that S598<sub>Q600Y</sub> is heteroclitic, they did not provide a mechanism for the immune enhancement. To address this, we determined the crystal structures of the H-2K<sup>b</sup>/S598 (PDBid 2ZSV, Protein Data Bank Japan (<a href="http://www.pdbj.org/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.pdbj.org/</a>)) and H-2K<sup>b</sup>/S598<sub>Q600Y</sub> (PDBid 2ZSW) complexes to 1.8 &#x000c5; and 2.8 &#x000c5; resolution respectively. The structure of H-2K<sup>b</sup>/S598 consists of two heterodimers in the asymmetric unit (r.m.s.d. of 0.18 &#x000c5; for C&#x003b1; atoms), with the S598 peptide clearly bound in the antigen binding cleft of the heavy chains (HC, <a href="#ppat.1000186.s003" rid="ppat.1000186.s003" class=" supplementary-material">\n<strong>Figure S3A</strong>\n</a>). The two peptide copies display a virtually identical configuration with root mean square deviation (rmsd) values of only 0.09 &#x000c5; for all peptide atoms (0.05 &#x000c5; for C&#x003b1; atoms). The mode of S598 and S598<sub>Q600Y</sub> binding within the Ag-binding cleft is unambiguous, with the exception of Arg-1, whose side chain is partially disordered (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g005" rid-ob="ob-ppat-1000186-g005" co-legend-rid="lgnd_ppat-1000186-g005"><span>\n<strong>Figure 5A,D</strong>\n</span></a>\n<a href="#ppat.1000186.s003" rid="ppat.1000186.s003" class=" supplementary-material">\n<strong>; Figure S3C</strong>\n</a>). The S598 peptide adopts an extended conformation, with the side chains of Arg-1, Ile-4 and Asn-7 extending prominently out of the cleft (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g005" rid-ob="ob-ppat-1000186-g005" co-legend-rid="lgnd_ppat-1000186-g005"><span>\n<strong>Figure 5C</strong>\n</span></a>). Ala-6 is also largely solvent exposed with its side chain pointing towards the &#x003b1;2 helix, while the side chains of Cys (Aba)-2, Gln-3, Phe-5 and Ile-8 are buried within the cleft. While the cysteine analogue\'s side chain is not involved in any hydrophilic interactions, there are a number of suitably positioned hydrogen bonding partners (Glu-24, Tyr-45 and Asn-70), with which the original thiol side chain could potentially interact (<strong><a href="#ppat.1000186.s003" rid="ppat.1000186.s003" class=" supplementary-material">Figure S3B</a>; <a href="#ppat.1000186.s005" rid="ppat.1000186.s005" class=" supplementary-material">Table S2</a></strong>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="ppat-1000186-g005" co-legend-rid="lgnd_ppat-1000186-g005"><a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g005/" target="figure" rid-figpopup="ppat-1000186-g005" rid-ob="ob-ppat-1000186-g005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140686722939488" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2563037_ppat.1000186.g005.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is ppat.1000186.g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2563037/bin/ppat.1000186.g005.jpg" /></a></div><div id="largeobj_idm140686722939488" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_ppat-1000186-g005"><div><a class="figpopup" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g005/" target="figure" rid-figpopup="ppat-1000186-g005" rid-ob="ob-ppat-1000186-g005">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Refined structures of WT and Q600Y S598-Aba bound to H-2K<sup>b</sup>.</strong><p id="__p28">(A) View of the H-2K<sup>b</sup> antigen binding cleft from above. The HC is shown as a cartoon representation and coloured slate. The peptide is in stick format with carbon atoms coloured yellow. The final 2<em>F<sub>o</sub>-F<sub>c</sub></em> map density for the peptide contoured at 1.0 &#x003c3; is shown as a magenta mesh. (B) Detail of the antigen binding cleft displaying key interactions (dashed lines) between H-2K<sup>b</sup> and S598-Aba in the region surrounding position 3 of the peptide. Selected residues of the HC are drawn in stick format (slate carbon atoms). Peptide residues are labelled in italics. (C) Surface representation of the H-2K<sup>b</sup>/S598-Aba complex as seen from above. Peptide residues Arg-1, Ile-4 and Asn-7 are coloured wheat. Position 3 of the peptide (Gln) is coloured red and the HC residue E-152 is purple. <em>D</em>, <em>E</em> and <em>F</em>, Equivalencies to A, B and C, respectively, for the H-2K<sup>b</sup>/S598<sub>Q600Y</sub>-Aba structure. In these panels the HC is drawn in green and the peptide in cyan.</p></div></div></div><p id="__p29">In addition to main chain interactions across the length of the peptide, S598 is anchored to the MHC via the side chains of Gln-3, Phe-5 and Ile-8. Gln-3 forms hydrogen bonds with the Ser-99 and Gln-114 of the HC <strong>(</strong>\n<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g005" rid-ob="ob-ppat-1000186-g005" co-legend-rid="lgnd_ppat-1000186-g005"><span>\n<strong>Figure 5B</strong>\n</span></a>\n<strong>)</strong>, while Phe-5 and Ile-8 are buried within hydrophobic pockets. In addition, the side chains of Phe-5 and Gln-3 pack against each other and between the aromatic rings of HC residues Tyr-159 and Phe-74, constraining the peptide\'s backbone conformation at those positions.</p><p id="__p30">The structure of H-2K<sup>b</sup>/S598<sub>Q600Y</sub> consists of four heterodimers in the asymmetric unit (rmsd of 0.09 &#x000c5; for heavy chain (HC) C&#x003b1;\'s), the four copies of the peptide adopting virtually identical conformations (rmsd of 0.12 &#x000c5; for all peptide atoms and 0.05 &#x000c5; for C&#x003b1; atoms). S598<sub>Q600Y</sub> displays the same conformation as the S598 determinant (the average rmsd for peptide C&#x003b1; atoms between the two structures is 0.24 &#x000c5;) and forms equivalent interactions with the MHC. The only prominent structural difference is observed at the mutated position (Q3&#x02192;Y3) (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g005" rid-ob="ob-ppat-1000186-g005" co-legend-rid="lgnd_ppat-1000186-g005"><span>\n<strong>Figure 5B,E</strong>\n</span></a>\n<strong>, </strong>\n<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g006" rid-ob="ob-ppat-1000186-g006" co-legend-rid="lgnd_ppat-1000186-g006"><span>\n<strong>6A,B</strong>\n</span></a>). In contrast to Gln-3, the Tyr-3 side chain is oriented towards the &#x003b1;-2 helix rather than the floor of the cleft. Consequently, the interactions with Ser-99 and Gln-114 of the HC are lost and instead the tyrosine\'s hydroxyl group forms a hydrogen bond with the side chain of Glu-152 (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g005" rid-ob="ob-ppat-1000186-g005" co-legend-rid="lgnd_ppat-1000186-g005"><span>\n<strong>Figure 5E</strong>\n</span></a>). The side chain of Tyr-3 also forms a number of close contacts with the residues in its immediate environment, specifically HC residues Gln-114, Arg-155, Leu-156 and Tyr-159, as well as intramolecular interactions with Phe-5 (<a href="#ppat.1000186.s005" rid="ppat.1000186.s005" class=" supplementary-material">\n<strong>Table S2</strong>\n</a>). In addition to Tyr-3, deviations of potential significance (&#x0003e;0.5 &#x000c5;) in the peptide structures that are attributable to the Q660Y mutation are observed at Ile-4 and Phe-5.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="ppat-1000186-g006" co-legend-rid="lgnd_ppat-1000186-g006"><a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g006/" target="figure" rid-figpopup="ppat-1000186-g006" rid-ob="ob-ppat-1000186-g006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140686713325744" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2563037_ppat.1000186.g006.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is ppat.1000186.g006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2563037/bin/ppat.1000186.g006.jpg" /></a></div><div id="largeobj_idm140686713325744" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_ppat-1000186-g006"><div><a class="figpopup" href="/pmc/articles/PMC2563037/figure/ppat-1000186-g006/" target="figure" rid-figpopup="ppat-1000186-g006" rid-ob="ob-ppat-1000186-g006">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Comparison of the WT and Q600Y S598-Aba complexes with H-2K<sup>b</sup>.</strong><p id="__p31">Superpositions were carried out using the C&#x003b1; atoms of HC residues 1&#x02013;176. (A) View of the H-2K<sup>b</sup> antigen binding cleft from above. The HC backbone is shown in ribbon format and the peptide residues as sticks. The index determinant is drawn with yellow carbons and the Q600Y variant with cyan. This colour scheme is extended to include the HC carbon atoms of the same structure. (B) Detail of the antigen binding cleft showing conformational differences between the WT and Q600Y structures in the region surrounding position 3 of the peptide.</p></div></div></div><p id="__p32">Overall the S598 determinant displays greater complementarity for the antigen binding cleft of H-2K<sup>b</sup> in its N-terminal region, with few stabilizing interactions observed between the HC and positions 6 and 7. (<strong><a href="#ppat.1000186.s003" rid="ppat.1000186.s003" class=" supplementary-material">Figure S3B, D</a>; <a href="#ppat.1000186.s005" rid="ppat.1000186.s005" class=" supplementary-material">Table S2</a></strong>). Nevertheless, a pocket is observed between the &#x003b1;-2 helix and the peptide near position 3 in the index structure that is filled by the steric bulk of Tyr-3 in the Q600Y structure <strong>(</strong>\n<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g005" rid-ob="ob-ppat-1000186-g005" co-legend-rid="lgnd_ppat-1000186-g005"><span>\n<strong>Figure 5C,F</strong>\n</span></a>\n<strong>)</strong>. This increase in surface complementarity and the greater number of observed interactions resulting from the Q3&#x02192;Y3 mutation would account for the enhanced thermostability (&#x0223c;10&#x000b0;C) measured for the H-2K<sup>b</sup>/S598<sub>Q600Y</sub>&#x02013;Aba complex by circular dichroism (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g001" rid-ob="ob-ppat-1000186-g001" co-legend-rid="lgnd_ppat-1000186-g001"><span>\n<strong>Figure 1</strong>\n</span></a>). This increase in complementarity of the MHC for S598<sub>Q600Y</sub> and the greater stability of the resulting complex were predicted from comparisons of the WT determinant complex with existing structures of H-2K<sup>b</sup> bound with peptides similar to S598 and possessing the consensus tyrosine anchor residue at position 3, as well as another aromatic residue at position 5.</p><p id="__p33" class="p p-last">With respect to the HC, the &#x003b1;-1 and &#x003b1;-2 domains of the two structures superimpose well with an rmsd of 0.37 &#x000c5; for C&#x003b1; atoms (residues 1&#x02013;176). Nevertheless, significant deviations (&#x0003e;0.5 &#x000c5;) are observed between the two structures at a number of positions in the region of the antigen binding cleft. In particular, changes in the conformation of Ser-99, Gln-114, and Gly-151-Glu-154 are associated with the bound peptides. Changes in the side chain conformations of Ser-99 and Gln-114 in the Q600Y complex structure are consistent with the loss of hydrogen bonding interactions with position 3. In the wild type peptide structure, Glu-152 forms a salt bridge with Arg-155, the guanadinium group of which also forms a hydrogen bond with the main chain carbonyl group of the peptide\'s Ile-4. While these interactions are maintained in the Q600Y complex, the side chain of Glu-152 displays a conformational shift consistent with the formation of a hydrogen bond with the peptide\'s Tyr-3 (<a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g006" rid-ob="ob-ppat-1000186-g006" co-legend-rid="lgnd_ppat-1000186-g006"><span>\n<strong>Figure 6</strong>\n</span></a>). Interestingly the region of the &#x003b1;-2 helix around Glu-152 (Gly-151 - Glu-154) also displays significant main chain and side chain deviations between the two structures (rmsd of 0.77 &#x000c5; for C&#x003b1; atoms; <a href="/pmc/articles/PMC2563037/figure/ppat-1000186-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="ppat-1000186-g006" rid-ob="ob-ppat-1000186-g006" co-legend-rid="lgnd_ppat-1000186-g006"><span>\n<strong>Figure 6</strong>\n</span></a>). Thus, consistent with the functional analyses, the structure of the heteroclitic variant of the S598 epitope displays relatively small changes in conformation yet the combination of these subtle changes in the TcR accessible residues and the structural landscape of the MHCp in addition to the enhanced stability of the complex lead to more efficacious CTL responses.</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Discussion</h2><p id="__p34" class="p p-first">We describe the identification of a heteroclitic determinant that enhances recognition by virus-specific CD8 T cells, and use the crystal structure of the new determinant (S598<sub>Q600Y</sub>) to provide a basis why it elicits an enhanced CTL response. Comparison of S598 to the consensus binding motif suggested a suboptimal interaction with the H-2K<sup>b</sup> molecule at the secondary anchor position (Gln-3) and, consequently, an approach to enhance the immunogenicity of the determinant. Replacement of the Gln-3 with Tyr-3 (Q600Y) did, indeed, result in an determinant with increased thermostability without diminishing the CD8 T cell response. Most strikingly, the Q600Y change resulted in subtle changes in the conformation of the &#x003b1;-2 helix locally in the vicinity of Glu-152. These subtle changes are likely critical for the enhanced TcR recognition that we detected.</p><p id="__p35">S598<sub>Q600Y</sub> elicited a response with higher functional avidity to both the cognate and native determinants than S598, and this was not reflected in differential V&#x003b2; usage. The T cell response to S598 in rJ-infected mice is very diverse <a href="#ppat.1000186-Pewe4" rid="ppat.1000186-Pewe4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680473">[35]</a>. As assessed by V&#x003b2; usage, the response to S598 and S598<sub>Q600Y</sub> in rJ.S598<sub>Q600Y</sub> was similarly diverse with only modest differences noted when cells from mice primed by S598 and S598<sub>Q600Y</sub> were compared. While we cannot exclude the possibility that cross-reacting S598-specific cells primed by S598<sub>Q600Y</sub> are biased for V&#x003b2; chains not analyzed in this study, it is more likely that the fine specificity of the complementarity-determining region 3 (CDR3) determines their greater affinity for H-2K<sup>b</sup>/S598. Although an increase in stability of the MHC class I/peptide complex is not generally expected to enhance TcR affinity for the complex, similar results have been observed in mice immunized with analogues to a common tumor antigen <a href="#ppat.1000186-Chen1" rid="ppat.1000186-Chen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680533">[36]</a>.</p><p id="__p36">One unexpected result was that S598 exhibited both low MHC class I and low TcR avidity. Previous studies showed that this determinant exhibited low functional avidity <a href="#ppat.1000186-Castro1" rid="ppat.1000186-Castro1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680501">[21]</a>, but it was not known whether this reflected low binding to the MHC class I or to the TcR. Assuming that low affinity for MHC class I results in a low effective concentration of H-2K<sup>b</sup>/S598 complex on the cell surface, the responding T cells should be high avidity, based, primarily, on <em>in vitro</em> studies <a href="#ppat.1000186-AlexanderMiller1" rid="ppat.1000186-AlexanderMiller1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680527">[37]</a>. While the relationship between level of surface peptide and avidity of the responding T cells generated in vivo is not as clearcut <a href="#ppat.1000186-Bullock1" rid="ppat.1000186-Bullock1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680526">[38]</a>, there is no obvious explanation for how a peptide with low MHC class I binding also elicits a low avidity T cell response. This selection of only a subset of CD8 T cells capable of responding to S598 may partly explain why S598-primed cells do not recognize the Q600Y determinant.</p><p id="__p37">The biological significance of the heteroclitic Q600Y determinant was shown by its ability to protect JHMV-infected mice from CTL escape at S510 and to diminish clinical disease. This was important to demonstrate because other studies, using tumor models, have shown that immunogenicity and tumor recognition are not necessarily concordant <a href="#ppat.1000186-Rubio1" rid="ppat.1000186-Rubio1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680475">[39]</a>. Mutations resulting in CTL escape occur most commonly in determinants that are exposed to high selective pressure <a href="#ppat.1000186-Boon1" rid="ppat.1000186-Boon1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680525">[40]</a>&#x02013;<a href="#ppat.1000186-Leslie1" rid="ppat.1000186-Leslie1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680503">[42]</a> and outgrowth of CTL escape variants is efficiently suppressed by effective and rapid virus clearance <a href="#ppat.1000186-Erickson1" rid="ppat.1000186-Erickson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680505">[43]</a>&#x02013;<a href="#ppat.1000186-Tester1" rid="ppat.1000186-Tester1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680489">[46]</a>, as occurs in mice infected with rJ.S<sub>Q600Y</sub>. Thus, even though CTL escape is not detected in normal mice infected with LCMV or influenza, escape does occur when mice transgenic for a single LCMV-specific TcR are infected with high amounts of virus <a href="#ppat.1000186-Moskophidis1" rid="ppat.1000186-Moskophidis1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680482">[44]</a>,<a href="#ppat.1000186-Pircher1" rid="ppat.1000186-Pircher1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680490">[47]</a>. Under these conditions, the immune response is highly focused on a single CD8 T cell determinant and virus replication continues for extended periods of time, facilitating mutation at the targeted determinant.</p><p id="__p38">In mice infected with wild type JHMV, the CTL response is functionally focused on S510 <a href="#ppat.1000186-Castro1" rid="ppat.1000186-Castro1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680538">[21]</a>; the Q600Y substitution effectively prevents CTL escape at either S510 or S598<sub>Q600Y</sub> by the induction of a second high avidity CTL response. Mutations in S598<sub>Q600Y</sub> were not detected even when the CTL response was directed primarily at this determinant (e.g. mice infected with rJ.S<sub>W513R</sub>&#x0002b;<sub>Q600Y</sub>). Consistent with this inability to readily tolerate mutations, we were unable to generate recombinant virus mutated in position Ile-4 (I601D,E,K,R,T) and recombinant virus mutated at Phe-5 (F602A) was highly attenuated (data not shown). The combination of induction of high avidity CTL and inability to tolerate mutation without adversely affecting virus fitness make S598<sub>Q600Y</sub> an ideal target for the anti-JHMV CTL response. Further, the ala scanning results suggest that S598<sub>Q600Y</sub>-specific CTLs may more readily tolerate changes in the H-2K<sup>b</sup>/peptide complex, and this plasticity would also minimize the likelihood of CTL escape. In contrast, we have previously shown that introduction of the LCMV-specific GP33 determinant, which also elicits CTL with high functional avidity, into JHMV greatly diminished clinical disease but did not prevent CTL escape <a href="#ppat.1000186-Kim1" rid="ppat.1000186-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680488">[22]</a>. The GP33 determinant was introduced at a site in the genome that tolerated mutation and deletion and intact determinant was no longer present in virus by day 20 p.i. Collectively these results suggest that a response to a second determinant that elicits CTL exhibiting high functional avidity at early times p.i. results in enhanced suppression of virus replication, but its presence throughout the infection is required to protect against CTL escape.</p><p id="__p39" class="p p-last">In conclusion, we have demonstrated that crystal structures are useful in gaining an understanding of the basis of heteroclitic epitopes and can also prove valuable in guiding the rational design of &#x0201c;better&#x0201d; CTL epitopes. In our mouse system, immunization with the heteroclitic determinant resulted in the generation of unique populations of CTL that respond with high functional avidity to an otherwise modestly immunogenic viral epitope. The generation of unique populations of CTL that respond with high functional avidity to weakly immunogenic epitopes will be useful for the treatment and prevention of human infectious diseases. Our proposed structure-guided approach has direct application to HIV, HCV and other chronic infections in which virus persistence and CTL escape occurs. By modulating T cell immunity through prophylactic or therapeutic peptide-based vaccination, virus titers may be reduced and CTL escape and other consequences of viral persistence circumvented.</p></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Materials and Methods</h2><div id="s4a" class="sec sec-first"><h3 id="s4atitle">Mice</h3><p id="__p40" class="p p-first-last">Specific pathogen-free B6 and BALB/c mice were obtained from National Cancer Institute (Bethesda, MD). To obtain infected mice in which CTL escape at S510 was detected, suckling B6 mice were infected intranasally with 2&#x02013;4&#x000d7;10<sup>4</sup> PFU of recombinant JHMV at 10 days of age and nursed by dams that were immunized with JHMV, as described previously <a href="#ppat.1000186-Perlman1" rid="ppat.1000186-Perlman1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_850014200">[27]</a>. For experiments comparing multiple JHMV variants, each litter served as an internal control: equal numbers of pups were infected with rJ and one to three recombinant variant viruses, depending on litter size. All animal studies were approved by the University of Iowa Animal Care and Use Committee.</p></div><div id="s4b" class="sec"><h3 id="s4btitle">Intracellular cytokine staining</h3><p id="__p41" class="p p-first-last">Mononuclear cells were harvested from the brains of acutely ill mice 7 days p.i. and analyzed for expression of IFN-&#x003b3; by an intracellular cytokine staining protocol as previously described <a href="#ppat.1000186-Wu1" rid="ppat.1000186-Wu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680537">[28]</a>. Unless otherwise noted, peptides corresponding to epitopes were used at a final concentration of 1 &#x000b5;M and cells were stimulated in the presence of 500 &#x000b5;M TCEP (Sigma, St. Louis, MO). Cells were analyzed using a FACScan flow cytometer (BD Biosciences, Mountain View, CA). Data sets were analyzed using FlowJo software (Tree Star, Inc, Ashland, OR). All antibodies and reagents were purchased from BD Pharmingen (San Diego, CA).</p></div><div id="s4c" class="sec"><h3 id="s4ctitle">Recombinant viruses</h3><p id="__p42" class="p p-first-last">Recombinant wild-type and S510 and S598 variants of JHMV were generated as previously described <a href="#ppat.1000186-Kuo1" rid="ppat.1000186-Kuo1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680494">[48]</a>,<a href="#ppat.1000186-Ontiveros1" rid="ppat.1000186-Ontiveros1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680502">[49]</a>. Briefly, overlapping extension polymerase chain reaction (PCR) was used to generate the S598<sub>Q600Y</sub> and S510<sub>W513R</sub> variants. Primers that overlapped the glutamine at residue 600 of the spike glycoprotein were (5&#x02032; to 3&#x02032;) Q600Y fwd, <em class="gene">ATGATCGCTGC<span class="underline">TAT</span>ATTTTTGCTAACATATTG</em>; Q600Y rev, <em class="gene">AATATGTTAGCAAAAAT<span class="underline">ATA</span>GCAGCGATCAT</em>. Primers that overlapped the tryptophan at residue 513 were (5&#x02032; to 3&#x02032;) W513R fwd, <em class="gene">GTGAGTGTTCTCTT<span class="underline">CGG</span>AATGGGCCCCATTTGCGCTCGGC</em>; W513R rev, <em class="gene">AGCGCAAATGGGGCCCATT<span class="underline">CCG</span>AAGAGAACACTCAC</em>. The outer primers for each targeted change were fwd, <em class="gene">TGTTGATTGCGCCAGCAGCTACATTAG</em>; and rev, <em class="gene">ACCTACGGATTGAACGCTATCATTGAC</em>. Underlined nucleotides correspond to the nucleotides encoding the Gln to Tyr and Trp to Arg substitutions within S598 and S510, respectively. Recombinant viruses encoding the variant epitope(s) were selected, propagated and titered as previously described <a href="#ppat.1000186-Ontiveros1" rid="ppat.1000186-Ontiveros1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680532">[49]</a>. At least two independent isolates of each recombinant virus were analyzed.</p></div><div id="s4d" class="sec"><h3 id="s4dtitle">One-step viral growth kinetics</h3><p id="__p43" class="p p-first-last">Virus was inoculated onto confluent 17Cl-1 monolayers in a 12-well plate at a multiplicity of infection (MOI) of 1.0. Groups of cells were harvested at the indicated time points and total virus (cell-associated and cell-free) was titered as previously described <a href="#ppat.1000186-Perlman1" rid="ppat.1000186-Perlman1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_850014202">[27]</a>.</p></div><div id="s4e" class="sec"><h3 id="s4etitle">\n<em>In vivo</em> virus competition assay</h3><p id="__p44" class="p p-first-last">Equal PFU (2&#x02013;4&#x000d7;10<sup>4</sup>) of rJ and rJ.S<sub>Q600Y</sub> were combined and inoculated intranasally into 5-week-old B6 and BALB/c mice. Total RNA was harvested from the brains of mice 7 days p.i. and the relative representation of WT (wild type) versus variant template was determined by RT-PCR and sequencing. This assay can specifically detect a given species of template when that species comprises at least 20&#x00025; of a heterogeneous pool <a href="#ppat.1000186-Ogino1" rid="ppat.1000186-Ogino1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680534">[50]</a>. Primers used were (5&#x02032;-3&#x02032;): forward, <em class="gene">AACCCCTCGTCTTGGAATAGGAGGTATGG</em>; and reverse, <em class="gene">CCTACGGATTGAACGCTATCATTGACTAAC</em>. PCR products were sequenced directly by the University of Iowa DNA Core.</p></div><div id="s4f" class="sec"><h3 id="s4ftitle">Alanine scans and functional avidity determination</h3><p id="__p45" class="p p-first-last">For alanine scanning, cells were stimulated <em>ex vivo</em> with the indicated concentration of native or variant peptide and stained for CD8 and IFN-&#x003b3; as described above. Data were normalized to the frequency of cells that reacted to the unmodified S598 or S598<sub>Q600Y</sub> peptides. For functional avidity determination, mononuclear cells were harvested from the brains of rJ or rJ.S598<sub>Q600Y</sub>-infected mice 7 days p.i. and stimulated <em>ex vivo</em> in the presence of EL-4 cells pulsed with tenfold dilutions of peptide corresponding to native S598 or S598<sub>Q600Y</sub> epitopes. After 5.5 hours, cells were stained for intracellular IFN-&#x003b3; as described above. For each epitope-specific population, data were normalized to the frequency of antigen-specific CTL detected using the highest titration of peptide (1 &#x000b5;M).</p></div><div id="s4g" class="sec"><h3 id="s4gtitle">Circular dichroism</h3><p id="__p46" class="p p-first-last">CD spectra were measured on a Jasco 810 spectropolarimeter using a thermostatically controlled cuvette at temperatures between 30 and 90&#x000b0;C. Far-UV spectra were collected and analyzed as described <a href="#ppat.1000186-Webb1" rid="ppat.1000186-Webb1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680521">[23]</a>.</p></div><div id="s4h" class="sec"><h3 id="s4htitle">TcR V&#x003b2; chain usage</h3><p id="__p47" class="p p-first-last">Cells were harvested from the CNS of mice 7 days p.i. and stimulated <em>ex vivo</em> with S598 or S598<sub>Q600Y</sub> peptides. Cell aliquots were subsequently stained for CD8 (PE-Cy7-anti-CD8&#x003b1;) and V&#x003b2; (FITC-anti-V&#x003b2;2, 3, 4, 5.1/5.2, 6, 7, 8, 9, 10<sup>b</sup>, 11, 12, 13 or 14, BD-Pharmingen) followed by intracellular staining for IFN-&#x003b3; (PE-anti-IFN-&#x003b3;). Data were collected using a Becton Dickinson LSR II instrument at the University of Iowa Flow Cytometry Facility. Data are expressed as the proportion of antigen-specific CD8 T cells that express each V&#x003b2; chain.</p></div><div id="s4i" class="sec"><h3 id="s4ititle">RNA sequence analysis</h3><p id="__p48" class="p p-first-last">Total RNA was purified with TRIzol (Invitrogen, Carlsbad, CA) from the CNS of mice. The 1055 base pair region of the spike glycoprotein encompassing both S510 and S598 was amplified by RT-PCR and sequenced directly as previously described <a href="#ppat.1000186-Butler2" rid="ppat.1000186-Butler2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680478">[19]</a>.</p></div><div id="s4j" class="sec"><h3 id="s4jtitle">Dendritic cell immunization and JHMV challenge</h3><p id="__p49" class="p p-first-last">Bone marrow-derived DC were prepared, pulsed with peptides and injected into mice as previously described <a href="#ppat.1000186-Hamilton1" rid="ppat.1000186-Hamilton1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680484">[51]</a>. Briefly, 5&#x000d7;10<sup>5</sup> LPS-matured DC were left uncoated, coated with S598 or S598<sub>Q600Y</sub> peptides and injected via tail vein into groups of 4-week-old mice. Seven days following DC-vaccination, mice were infected intranasally with 4&#x000d7;10<sup>4</sup> PFU of JHMV. Seven days following virus infection, brains were harvested from mice and the frequencies of epitope-specific CD8 T cells were determined by <em>ex vivo</em> stimulation and intracellular cytokine staining as described above. In independent studies, DC-S598 and DC-S598<sub>Q600Y</sub> priming was verified by harvesting spleens from several mice seven days following DC-vaccination.</p></div><div id="s4k" class="sec"><h3 id="s4ktitle">Crystal structure of H-2K<sup>b</sup>/S598 and H-2K<sup>b</sup>/S598<sub>Q600Y</sub> complexes</h3><p id="__p50" class="p p-first-last">Crystals of H-2K<sup>b</sup>S598-Aba were grown at 21&#x000b0;C in 0.1 M cacodylate pH 6.6, 16&#x00025; PEG (polyethylene glycol) 8,000, 0.2 M Ca(OAc)<sub>2</sub>, using a protein concentration of 9 mg/ml. Crystals were cryoprotected by stepwise equilibration against mother liquor containing 5, 10 and 15&#x00025; glycerol and flash frozen by placing in a nitrogen stream. A 1.8 &#x000c5; resolution dataset was collected on an in-house X-ray source. Crystals of H-2K<sup>b</sup>S598<sub>Q600Y</sub>-Aba were grown at 21&#x000b0;C in 0.1 M cacodylate pH 6.5, 13&#x00025; PEG 8,000, 0.2 M Ca(OAc)<sub>2</sub>, using a protein concentration of 6 mg/ml. Crystals were cryoprotected by gradual equilibration against mother liquor containing 20&#x00025; PEG 8,000 and 5&#x00025; glycerol before flash freezing. A 2.8 &#x000c5; resolution dataset was collected on an in-house source. The WT data were integrated in <em>MOSFLM</em>\n<a href="#ppat.1000186-Leslie2" rid="ppat.1000186-Leslie2" class=" bibr popnode">[52]</a> and scaled/merged using <em>SCALA</em>\n<a href="#ppat.1000186-Evans1" rid="ppat.1000186-Evans1" class=" bibr popnode">[53]</a>. The Q600Y variant data were processed using <em>HKL2000</em>. Both structures were solved by molecular replacement in <em>PHASER</em>\n<a href="#ppat.1000186-Storoni1" rid="ppat.1000186-Storoni1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680499">[54]</a>, against previously solved H-2K<sup>b</sup> complexes (PDBid\'s: 1G7Q and 1RJY, respectively). The resultant models underwent iterative cycles of refinement in <em>PHENIX</em>\n<a href="#ppat.1000186-Afonine1" rid="ppat.1000186-Afonine1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_628026570">[55]</a> and, <em>REFMAC5</em>\n<a href="#ppat.1000186-Murshudov1" rid="ppat.1000186-Murshudov1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680535">[56]</a> (restrained and TLS refinement) followed by model building/correction in <em>COOT</em>\n<a href="#ppat.1000186-Emsley1" rid="ppat.1000186-Emsley1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_627680487">[57]</a>. The solvent structures were built using <em>ARP/wARP</em>\n<a href="#ppat.1000186-Lamzin1" rid="ppat.1000186-Lamzin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_628026571">[58]</a> and <em>COOT</em>. A summary of the processing and refinement statistics is presented in <a href="#ppat.1000186.s004" rid="ppat.1000186.s004" class=" supplementary-material">Table S1</a>.</p></div><div id="s4l" class="sec sec-last"><h3 id="s4ltitle">Statistical analyses</h3><p id="__p51" class="p p-first-last">Statistical significance was determined by nonpaired, two-sided Student\'s <em>t</em> test or chi-squared test, where indicated.</p></div></div><div id="s5" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="s5title">Supporting Information</h2><!--/article/body/sec/--><div class="sec suppmat" id="ppat.1000186.s001"><h4>Figure S1</h4><p id="__p52">Immunogenicity of the Aba-modified, S598 peptidomimetic. (A) Intracellular IFN-&#x003b3; staining of splenocytes from mice peripherally immunized with JHMV simulated ex vivo with peptides (1 &#x000b5;M) corresponding to the native or Aba-modified S598 determinant. (B) Native S598 peptide is more stimulatory when S598-specific CTL are stimulated in the presence of reducing agent. Splenocytes were harvested from JHMV-immune mice and reacted with native S598 peptide (1 &#x000b5;M) in the presence of 500 &#x000b5;M TCEP. Data in A represent the mean&#x000b1;SEM for 3 experiments. Data in B are representative of five independent experiments.</p><p id="__p53">(0.25 MB TIF)</p><div class="sup-box half_rhythm" id="idm140686719291664"><a href="/pmc/articles/PMC2563037/bin/ppat.1000186.s001.tif" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(240K, tif)</sup></div></div><div class="sec suppmat" id="ppat.1000186.s002"><h4>Figure S2</h4><p id="__p55">TCR V&#x003b2; chain usage and alanine scanning analysis. (A) Total mononuclear cells were harvested from mice infected with rJ or rJ.S<sub>Q600Y</sub> and stimulated <em>ex vivo</em> with S598 and S598<sub>Q600Y</sub> peptides, respectively. Following stimulation, aliquots of cells were surface stained for CD8 and the indicated V&#x003b2; chain followed by intracellular cytokine staining for IFN-&#x003b3;. (B) CNS-derived cells from rJ.S<sub>Q600Y</sub>-infected mice were stimulated <em>ex vivo</em> with peptides corresponding to native S598 or S598<sub>Q600Y</sub> epitopes. Following stimulation, cells were analyzed as described for (A). Data represent the fraction of IFN-&#x003b3;&#x0002b;CD8&#x0002b; T cells expressing each V&#x003b2; chain and are derived from cells pooled from 2&#x02013;3 individual mice. (C) Alanine scanning of the native S598 determinant. CNS-derived mononuclear cells were recovered from rJ-infected mice 7 days p.i. and stimulated <em>ex vivo</em> in the presence of 500 &#x000b5;M TCEP and 1 &#x000b5;M of the indicated peptide then stained for CD8 and intracellular IFN-&#x003b3;. Data are normalized to the frequency of epitope-specific cells detected when stimulated with the native S598 determinant. (D) Alanine scanning of the S598<sub>Q600Y</sub> determinant. Cells were harvested and tested as described for B except in this case the cells originated from the rJ.S<sub>Q600Y</sub>-infected CNS and were stimulated with 10 nM S598<sub>Q600Y</sub> peptide. (E) Alanine scanning of the S598 determinant recognized by S598<sub>Q600Y</sub>-primed, cross-reactive CTL. As in C, but cells were stimulated with 150 nM S598 peptide. For B&#x02013;D, concentrations of peptide equivalent to 10&#x000d7; that required for half maximal stimulation were used; data are mean&#x000b1;SEM from four independent experiments. Note that the differential responses to RCAIFANI in panels C and D reflect the differing amounts of peptide used in the two assays.</p><p id="__p56">(0.76 MB TIF)</p><div class="sup-box half_rhythm" id="idm140686722710768"><a href="/pmc/articles/PMC2563037/bin/ppat.1000186.s002.tif" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(743K, tif)</sup></div></div><div class="sec suppmat" id="ppat.1000186.s003"><h4>Figure S3</h4><p id="__p58">Refined structures of WT and Q600Y S598-Aba bound to H-2K<sup>b</sup>. (A) View of the H-2K<sup>b</sup> antigen binding cleft from above. The HC is shown as a cartoon representation and coloured slate. The peptide is in stick format with carbon atoms coloured yellow. The unbiased <em>F<sub>o</sub>-F<sub>c</sub></em> map density for the peptide contoured at 2.5 &#x003c3; is shown as a magenta mesh. (B) The same view as in A displaying key interactions (dashed lines) between H-2K<sup>b</sup> and S598-Aba. Selected residues of the HC are drawn in stick format (slate carbon atoms) and ordered water molecules are shown as red spheres. Peptide residues are labelled in italics. C and D, Equivalencies to A and B, respectively, for the H-2K<sup>b</sup>/S598<sub>Q600Y</sub>-Aba structure. In these panels the HC is drawn in green and the peptide in cyan.</p><p id="__p59">(4.07 MB EPS)</p><div class="sup-box half_rhythm" id="idm140686705392832"><a href="/pmc/articles/PMC2563037/bin/ppat.1000186.s003.eps" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(3.8M, eps)</sup></div></div><div class="sec suppmat" id="ppat.1000186.s004"><h4>Table S1</h4><p id="__p61">Data collection and refinement statistics.</p><p id="__p62">(0.06 MB DOC)</p><div class="sup-box half_rhythm" id="idm140686752783760"><a href="/pmc/articles/PMC2563037/bin/ppat.1000186.s004.doc" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(57K, doc)</sup></div></div><div class="sec suppmat" id="ppat.1000186.s005"><h4>Table S2</h4><p id="__p64">Contacts between the S598 determinant and H-2K<sup>b</sup>.</p><p id="__p65">(0.07 MB DOC)</p><div class="sup-box half_rhythm" id="idm140686708586880"><a href="/pmc/articles/PMC2563037/bin/ppat.1000186.s005.doc" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(65K, doc)</sup></div></div></div><div id="idm140686708585280" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140686708585280title">Acknowledgments</h2><div class="sec"><p id="__p67">We thank James McCluskey, Frank Carbone and Stephen Turner for critical reading of the manuscript.</p></div></div><div id="idm140686708584544" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140686708584544title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140686708584416"><p id="__p68" class="p p-first-last">The authors have declared that no competing interests exist.</p></p><p class="fn sec" id="idm140686708583552"><p id="__p69" class="p p-first-last">This work was supported by NIH grant (R01 NS036592, S.P. and A.W.P.) and an NIH Predoctoral Training Grant on Mechanisms of Parasitism (T32 AI007511, N.S.B.). A.W.P. is a Senior Research Fellow and A.I.W. is a C.J. Martin Fellow of the National Health and Medical Research Council of Australia. J.R. is an Australian Research Council Federation Fellow.</p></p></div></div><div id="idm140686708307392" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140686708307392title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Bowen1">1. <span class="element-citation">Bowen DG, Walker CM. Mutational escape from CD8&#x0002b; T cell immunity: HCV evolution, from chimpanzees to man. <span><span class="ref-journal">J Exp Med. </span>2005;<span class="ref-vol">201</span>:1709\xe2\x80\x931714.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2213256/">PMC free article</a>]</span> [<a href="/pubmed/15939787" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Mutational+escape+from+CD8&#x0002b;+T+cell+immunity:+HCV+evolution,+from+chimpanzees+to+man.&amp;author=DG+Bowen&amp;author=CM+Walker&amp;volume=201&amp;publication_year=2005&amp;pages=1709-1714&amp;pmid=15939787&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Goulder1">2. <span class="element-citation">Goulder PJ, Watkins DI. HIV and SIV CTL escape: implications for vaccine design. <span><span class="ref-journal">Nat Rev Immunol. </span>2004;<span class="ref-vol">4</span>:630\xe2\x80\x93640.</span> [<a href="/pubmed/15286729" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Immunol&amp;title=HIV+and+SIV+CTL+escape:+implications+for+vaccine+design.&amp;author=PJ+Goulder&amp;author=DI+Watkins&amp;volume=4&amp;publication_year=2004&amp;pages=630-640&amp;pmid=15286729&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-McMichael1">3. <span class="element-citation">McMichael AJ, Phillips RE. Escape of human immunodeficiency virus from immune control. <span><span class="ref-journal">Annu Rev Immunol. </span>1997;<span class="ref-vol">15</span>:271\xe2\x80\x93296.</span> [<a href="/pubmed/9143689" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;title=Escape+of+human+immunodeficiency+virus+from+immune+control.&amp;author=AJ+McMichael&amp;author=RE+Phillips&amp;volume=15&amp;publication_year=1997&amp;pages=271-296&amp;pmid=9143689&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Oxenius1">4. <span class="element-citation">Oxenius A, Price DA, Trkola A, Edwards C, Gostick E, et al.  Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8&#x0002b; T cell responses and decrease in HIV-1-specific CD4&#x0002b; and CD8&#x0002b; T cell frequencies. <span><span class="ref-journal">J Infect Dis. </span>2004;<span class="ref-vol">190</span>:713\xe2\x80\x93721.</span> [<a href="/pubmed/15272399" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Loss+of+viral+control+in+early+HIV-1+infection+is+temporally+associated+with+sequential+escape+from+CD8&#x0002b;+T+cell+responses+and+decrease+in+HIV-1-specific+CD4&#x0002b;+and+CD8&#x0002b;+T+cell+frequencies.&amp;author=A+Oxenius&amp;author=DA+Price&amp;author=A+Trkola&amp;author=C+Edwards&amp;author=E+Gostick&amp;volume=190&amp;publication_year=2004&amp;pages=713-721&amp;pmid=15272399&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Draenert1">5. <span class="element-citation">Draenert R, Le Gall S, Pfafferott KJ, Leslie AJ, Chetty P, et al.  Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. <span><span class="ref-journal">J Exp Med. </span>2004;<span class="ref-vol">199</span>:905\xe2\x80\x93915.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2211885/">PMC free article</a>]</span> [<a href="/pubmed/15067030" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Immune+selection+for+altered+antigen+processing+leads+to+cytotoxic+T+lymphocyte+escape+in+chronic+HIV-1+infection.&amp;author=R+Draenert&amp;author=S+Le+Gall&amp;author=KJ+Pfafferott&amp;author=AJ+Leslie&amp;author=P+Chetty&amp;volume=199&amp;publication_year=2004&amp;pages=905-915&amp;pmid=15067030&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Seifert1">6. <span class="element-citation">Seifert U, Liermann H, Racanelli V, Halenius A, Wiese M, et al.  Hepatitis C virus mutation affects proteasomal epitope processing. <span><span class="ref-journal">J Clin Invest. </span>2004;<span class="ref-vol">114</span>:250\xe2\x80\x93259.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC449747/">PMC free article</a>]</span> [<a href="/pubmed/15254592" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Hepatitis+C+virus+mutation+affects+proteasomal+epitope+processing.&amp;author=U+Seifert&amp;author=H+Liermann&amp;author=V+Racanelli&amp;author=A+Halenius&amp;author=M+Wiese&amp;volume=114&amp;publication_year=2004&amp;pages=250-259&amp;pmid=15254592&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Timm1">7. <span class="element-citation">Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, et al.  CD8 epitope escape and reversion in acute HCV infection. <span><span class="ref-journal">J Exp Med. </span>2004;<span class="ref-vol">200</span>:1593\xe2\x80\x931604.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2212005/">PMC free article</a>]</span> [<a href="/pubmed/15611288" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=CD8+epitope+escape+and+reversion+in+acute+HCV+infection.&amp;author=J+Timm&amp;author=GM+Lauer&amp;author=DG+Kavanagh&amp;author=I+Sheridan&amp;author=AY+Kim&amp;volume=200&amp;publication_year=2004&amp;pages=1593-1604&amp;pmid=15611288&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Allen1">8. <span class="element-citation">Allen TM, Yu XG, Kalife ET, Reyor LL, Lichterfeld M, et al.  De novo generation of escape variant-specific CD8&#x0002b; T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. <span><span class="ref-journal">J Virol. </span>2005;<span class="ref-vol">79</span>:12952\xe2\x80\x9312960.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1235830/">PMC free article</a>]</span> [<a href="/pubmed/16188997" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=De+novo+generation+of+escape+variant-specific+CD8&#x0002b;+T-cell+responses+following+cytotoxic+T-lymphocyte+escape+in+chronic+human+immunodeficiency+virus+type+1+infection.&amp;author=TM+Allen&amp;author=XG+Yu&amp;author=ET+Kalife&amp;author=LL+Reyor&amp;author=M+Lichterfeld&amp;volume=79&amp;publication_year=2005&amp;pages=12952-12960&amp;pmid=16188997&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Turnbull1">9. <span class="element-citation">Turnbull EL, Lopes AR, Jones NA, Cornforth D, Newton P, et al.  HIV-1 epitope-specific CD8&#x0002b; T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. <span><span class="ref-journal">J Immunol. </span>2006;<span class="ref-vol">176</span>:6130\xe2\x80\x936146.</span> [<a href="/pubmed/16670322" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=HIV-1+epitope-specific+CD8&#x0002b;+T+cell+responses+strongly+associated+with+delayed+disease+progression+cross-recognize+epitope+variants+efficiently.&amp;author=EL+Turnbull&amp;author=AR+Lopes&amp;author=NA+Jones&amp;author=D+Cornforth&amp;author=P+Newton&amp;volume=176&amp;publication_year=2006&amp;pages=6130-6146&amp;pmid=16670322&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Friedrich1">10. <span class="element-citation">Friedrich TC, Frye CA, Yant LJ, O\'Connor DH, Kriewaldt NA, et al.  Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response. <span><span class="ref-journal">J Virol. </span>2004;<span class="ref-vol">78</span>:2581\xe2\x80\x932585.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC369222/">PMC free article</a>]</span> [<a href="/pubmed/14963161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Extraepitopic+compensatory+substitutions+partially+restore+fitness+to+simian+immunodeficiency+virus+variants+that+escape+from+an+immunodominant+cytotoxic-T-lymphocyte+response.&amp;author=TC+Friedrich&amp;author=CA+Frye&amp;author=LJ+Yant&amp;author=DH+O\'Connor&amp;author=NA+Kriewaldt&amp;volume=78&amp;publication_year=2004&amp;pages=2581-2585&amp;pmid=14963161&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Kelleher1">11. <span class="element-citation">Kelleher AD. Clustered mutations in HIV-1 Gag are consistently required for escape from HLA-B27 restricted CTL responses. <span><span class="ref-journal">J Exp Med. </span>2001;<span class="ref-vol">193</span>:375\xe2\x80\x93386.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2195921/">PMC free article</a>]</span> [<a href="/pubmed/11157057" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Clustered+mutations+in+HIV-1+Gag+are+consistently+required+for+escape+from+HLA-B27+restricted+CTL+responses.&amp;author=AD+Kelleher&amp;volume=193&amp;publication_year=2001&amp;pages=375-386&amp;pmid=11157057&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Purcell1">12. <span class="element-citation">Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2007;<span class="ref-vol">6</span>:404\xe2\x80\x93414.</span> [<a href="/pubmed/17473845" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=More+than+one+reason+to+rethink+the+use+of+peptides+in+vaccine+design.&amp;author=AW+Purcell&amp;author=J+McCluskey&amp;author=J+Rossjohn&amp;volume=6&amp;publication_year=2007&amp;pages=404-414&amp;pmid=17473845&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Okazaki1">13. <span class="element-citation">Okazaki T, Pendleton CD, Lemonnier F, Berzofsky JA. Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen. <span><span class="ref-journal">J Immunol. </span>2003;<span class="ref-vol">171</span>:2548\xe2\x80\x932555.</span> [<a href="/pubmed/12928405" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Epitope-enhanced+conserved+HIV-1+peptide+protects+HLA-A2-transgenic+mice+against+virus+expressing+HIV-1+antigen.&amp;author=T+Okazaki&amp;author=CD+Pendleton&amp;author=F+Lemonnier&amp;author=JA+Berzofsky&amp;volume=171&amp;publication_year=2003&amp;pages=2548-2555&amp;pmid=12928405&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Okazaki2">14. <span class="element-citation">Okazaki T, Pendleton CD, Sarobe P, Thomas EK, Iyengar S, et al.  Epitope enhancement of a CD4 HIV epitope toward the development of the next generation HIV vaccine. <span><span class="ref-journal">J Immunol. </span>2006;<span class="ref-vol">176</span>:3753\xe2\x80\x933759.</span> [<a href="/pubmed/16517744" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Epitope+enhancement+of+a+CD4+HIV+epitope+toward+the+development+of+the+next+generation+HIV+vaccine.&amp;author=T+Okazaki&amp;author=CD+Pendleton&amp;author=P+Sarobe&amp;author=EK+Thomas&amp;author=S+Iyengar&amp;volume=176&amp;publication_year=2006&amp;pages=3753-3759&amp;pmid=16517744&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Tangri1">15. <span class="element-citation">Tangri S, Ishioka GY, Huang X, Sidney J, Southwood S, et al.  Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide. <span><span class="ref-journal">J Exp Med. </span>2001;<span class="ref-vol">194</span>:833\xe2\x80\x93846.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2195959/">PMC free article</a>]</span> [<a href="/pubmed/11560998" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Structural+features+of+peptide+analogs+of+human+histocompatibility+leukocyte+antigen+class+I+epitopes+that+are+more+potent+and+immunogenic+than+wild-type+peptide.&amp;author=S+Tangri&amp;author=GY+Ishioka&amp;author=X+Huang&amp;author=J+Sidney&amp;author=S+Southwood&amp;volume=194&amp;publication_year=2001&amp;pages=833-846&amp;pmid=11560998&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Dyall1">16. <span class="element-citation">Dyall R, Bowne WB, Weber LW, LeMaoult J, Szabo P, et al.  Heteroclitic immunization induces tumor immunity. <span><span class="ref-journal">J Exp Med. </span>1998;<span class="ref-vol">188</span>:1553\xe2\x80\x931561.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2212523/">PMC free article</a>]</span> [<a href="/pubmed/9802967" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Heteroclitic+immunization+induces+tumor+immunity.&amp;author=R+Dyall&amp;author=WB+Bowne&amp;author=LW+Weber&amp;author=J+LeMaoult&amp;author=P+Szabo&amp;volume=188&amp;publication_year=1998&amp;pages=1553-1561&amp;pmid=9802967&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Fikes1">17. <span class="element-citation">Fikes JD, Sette A. Design of multi-epitope, analogue-based cancer vaccines. <span><span class="ref-journal">Expert Opin Biol Ther. </span>2003;<span class="ref-vol">3</span>:985\xe2\x80\x93993.</span> [<a href="/pubmed/12943457" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Biol+Ther&amp;title=Design+of+multi-epitope,+analogue-based+cancer+vaccines.&amp;author=JD+Fikes&amp;author=A+Sette&amp;volume=3&amp;publication_year=2003&amp;pages=985-993&amp;pmid=12943457&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Butler1">18. <span class="element-citation">Butler NS, Dandekar AA, Perlman S. Antiviral antibodies are necessary to prevent cytotoxic T-lymphocyte escape in mice infected with a coronavirus. <span><span class="ref-journal">J Virol. </span>2007;<span class="ref-vol">81</span>:13291\xe2\x80\x9313298.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2168833/">PMC free article</a>]</span> [<a href="/pubmed/17913802" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Antiviral+antibodies+are+necessary+to+prevent+cytotoxic+T-lymphocyte+escape+in+mice+infected+with+a+coronavirus.&amp;author=NS+Butler&amp;author=AA+Dandekar&amp;author=S+Perlman&amp;volume=81&amp;publication_year=2007&amp;pages=13291-13298&amp;pmid=17913802&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Butler2">19. <span class="element-citation">Butler NS, Theodossis A, Webb AI, Dunstone MA, Nastovska R, et al.  Structural and biological basis of CTL escape in coronavirus-infected mice. <span><span class="ref-journal">J Immunol. </span>2008;<span class="ref-vol">180</span>:3926\xe2\x80\x933937.</span> [<a href="/pubmed/18322201" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Structural+and+biological+basis+of+CTL+escape+in+coronavirus-infected+mice.&amp;author=NS+Butler&amp;author=A+Theodossis&amp;author=AI+Webb&amp;author=MA+Dunstone&amp;author=R+Nastovska&amp;volume=180&amp;publication_year=2008&amp;pages=3926-3937&amp;pmid=18322201&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Pewe1">20. <span class="element-citation">Pewe L, Wu GF, Barnett EM, Castro RF, Perlman S. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. <span><span class="ref-journal">Immunity. </span>1996;<span class="ref-vol">5</span>:253\xe2\x80\x93262.</span> [<a href="/pubmed/8808680" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Cytotoxic+T+cell-resistant+variants+are+selected+in+a+virus-induced+demyelinating+disease.&amp;author=L+Pewe&amp;author=GF+Wu&amp;author=EM+Barnett&amp;author=RF+Castro&amp;author=S+Perlman&amp;volume=5&amp;publication_year=1996&amp;pages=253-262&amp;pmid=8808680&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Castro1">21. <span class="element-citation">Castro RF, Perlman S. CD8&#x0002b; T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. <span><span class="ref-journal">J Virol. </span>1995;<span class="ref-vol">69</span>:8127\xe2\x80\x938131.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC189767/">PMC free article</a>]</span> [<a href="/pubmed/7494335" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=CD8&#x0002b;+T-cell+epitopes+within+the+surface+glycoprotein+of+a+neurotropic+coronavirus+and+correlation+with+pathogenicity.&amp;author=RF+Castro&amp;author=S+Perlman&amp;volume=69&amp;publication_year=1995&amp;pages=8127-8131&amp;pmid=7494335&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Kim1">22. <span class="element-citation">Kim TS, Perlman S. Protection against CTL escape and clinical disease in a murine model of virus persistence. <span><span class="ref-journal">J Immunol. </span>2003;<span class="ref-vol">171</span>:2006\xe2\x80\x932013.</span> [<a href="/pubmed/12902505" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Protection+against+CTL+escape+and+clinical+disease+in+a+murine+model+of+virus+persistence.&amp;author=TS+Kim&amp;author=S+Perlman&amp;volume=171&amp;publication_year=2003&amp;pages=2006-2013&amp;pmid=12902505&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Webb1">23. <span class="element-citation">Webb AI, Dunstone MA, Chen W, Aguilar MI, Chen Q, et al.  Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:23438\xe2\x80\x9323446.</span> [<a href="/pubmed/15004033" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Functional+and+structural+characteristics+of+NY-ESO-1-related+HLA+A2-restricted+epitopes+and+the+design+of+a+novel+immunogenic+analogue.&amp;author=AI+Webb&amp;author=MA+Dunstone&amp;author=W+Chen&amp;author=MI+Aguilar&amp;author=Q+Chen&amp;volume=279&amp;publication_year=2004&amp;pages=23438-23446&amp;pmid=15004033&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Falk1">24. <span class="element-citation">Falk K, R&#x000f6;tzschke O, Stevanovic S, Jung G, Rammensee H-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. <span><span class="ref-journal">Nature. </span>1991;<span class="ref-vol">351</span>:290\xe2\x80\x93296.</span> [<a href="/pubmed/1709722" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Allele-specific+motifs+revealed+by+sequencing+of+self-peptides+eluted+from+MHC+molecules.&amp;author=K+Falk&amp;author=O+R&#x000f6;tzschke&amp;author=S+Stevanovic&amp;author=G+Jung&amp;author=H-G+Rammensee&amp;volume=351&amp;publication_year=1991&amp;pages=290-296&amp;pmid=1709722&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-vanBleek1">25. <span class="element-citation">van Bleek GM, Nathenson SG. The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self- peptides. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1991;<span class="ref-vol">88</span>:11032\xe2\x80\x9311036.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC53067/">PMC free article</a>]</span> [<a href="/pubmed/1763019" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=The+structure+of+the+antigen-binding+groove+of+major+histocompatibility+complex+class+I+molecules+determines+specific+selection+of+self-+peptides.&amp;author=GM+van+Bleek&amp;author=SG+Nathenson&amp;volume=88&amp;publication_year=1991&amp;pages=11032-11036&amp;pmid=1763019&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Mannering1">26. <span class="element-citation">Mannering SI, Harrison LC, Williamson NA, Morris JS, Thearle DJ, et al.  The insulin A-chain epitope recognized by human T cells is posttranslationally modified. <span><span class="ref-journal">J Exp Med. </span>2005;<span class="ref-vol">202</span>:1191\xe2\x80\x931197.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2213236/">PMC free article</a>]</span> [<a href="/pubmed/16260488" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=The+insulin+A-chain+epitope+recognized+by+human+T+cells+is+posttranslationally+modified.&amp;author=SI+Mannering&amp;author=LC+Harrison&amp;author=NA+Williamson&amp;author=JS+Morris&amp;author=DJ+Thearle&amp;volume=202&amp;publication_year=2005&amp;pages=1191-1197&amp;pmid=16260488&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Perlman1">27. <span class="element-citation">Perlman S, Schelper R, Bolger E, Ries D. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. <span><span class="ref-journal">Microb Pathog. </span>1987;<span class="ref-vol">2</span>:185\xe2\x80\x93194.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7135528/">PMC free article</a>]</span> [<a href="/pubmed/2853274" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Microb+Pathog&amp;title=Late+onset,+symptomatic,+demyelinating+encephalomyelitis+in+mice+infected+with+MHV-JHM+in+the+presence+of+maternal+antibody.&amp;author=S+Perlman&amp;author=R+Schelper&amp;author=E+Bolger&amp;author=D+Ries&amp;volume=2&amp;publication_year=1987&amp;pages=185-194&amp;pmid=2853274&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Wu1">28. <span class="element-citation">Wu GF, Dandekar AA, Pewe L, Perlman S. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. <span><span class="ref-journal">J Immunol. </span>2000;<span class="ref-vol">165</span>:2278\xe2\x80\x932286.</span> [<a href="/pubmed/10925317" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=CD4+and+CD8+T+cells+have+redundant+but+not+identical+roles+in+virus-induced+demyelination.&amp;author=GF+Wu&amp;author=AA+Dandekar&amp;author=L+Pewe&amp;author=S+Perlman&amp;volume=165&amp;publication_year=2000&amp;pages=2278-2286&amp;pmid=10925317&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Dandekar1">29. <span class="element-citation">Dandekar AA, Jacobsen G, Waldschmidt TJ, Perlman S. Antibody-mediated protection against cytotoxic T-cell escape in coronavirus-induced demyelination. <span><span class="ref-journal">J Virol. </span>2003;<span class="ref-vol">77</span>:11867\xe2\x80\x9311874.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC254260/">PMC free article</a>]</span> [<a href="/pubmed/14581523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Antibody-mediated+protection+against+cytotoxic+T-cell+escape+in+coronavirus-induced+demyelination.&amp;author=AA+Dandekar&amp;author=G+Jacobsen&amp;author=TJ+Waldschmidt&amp;author=S+Perlman&amp;volume=77&amp;publication_year=2003&amp;pages=11867-11874&amp;pmid=14581523&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Pewe2">30. <span class="element-citation">Pewe L, Xue S, Perlman S. Cytotoxic T-cell-resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus. <span><span class="ref-journal">J Virol. </span>1997;<span class="ref-vol">71</span>:7640\xe2\x80\x937647.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC192113/">PMC free article</a>]</span> [<a href="/pubmed/9311846" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Cytotoxic+T-cell-resistant+variants+arise+at+early+times+after+infection+in+C57BL/6+but+not+in+SCID+mice+infected+with+a+neurotropic+coronavirus.&amp;author=L+Pewe&amp;author=S+Xue&amp;author=S+Perlman&amp;volume=71&amp;publication_year=1997&amp;pages=7640-7647&amp;pmid=9311846&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Pewe3">31. <span class="element-citation">Pewe L, Perlman S. Immune response to the immunodominant epitope of mouse hepatitis virus is polyclonal, but functionally monospecific in C57Bl/6 mice. <span><span class="ref-journal">Virology. </span>1999;<span class="ref-vol">255</span>:106\xe2\x80\x93116.</span> [<a href="/pubmed/10049826" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Immune+response+to+the+immunodominant+epitope+of+mouse+hepatitis+virus+is+polyclonal,+but+functionally+monospecific+in+C57Bl/6+mice.&amp;author=L+Pewe&amp;author=S+Perlman&amp;volume=255&amp;publication_year=1999&amp;pages=106-116&amp;pmid=10049826&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Weiss1">32. <span class="element-citation">Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. <span><span class="ref-journal">Microbiol Mol Biol Rev. </span>2005;<span class="ref-vol">69</span>:635\xe2\x80\x93664.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1306801/">PMC free article</a>]</span> [<a href="/pubmed/16339739" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Microbiol+Mol+Biol+Rev&amp;title=Coronavirus+pathogenesis+and+the+emerging+pathogen+severe+acute+respiratory+syndrome+coronavirus.&amp;author=SR+Weiss&amp;author=S+Navas-Martin&amp;volume=69&amp;publication_year=2005&amp;pages=635-664&amp;pmid=16339739&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Anghelina1">33. <span class="element-citation">Anghelina D, Pewe L, Perlman S. Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis. <span><span class="ref-journal">Am J Pathol. </span>2006;<span class="ref-vol">169</span>:209\xe2\x80\x93222.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1698761/">PMC free article</a>]</span> [<a href="/pubmed/16816374" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&amp;title=Pathogenic+role+for+virus-specific+CD4+T+cells+in+mice+with+coronavirus-induced+acute+encephalitis.&amp;author=D+Anghelina&amp;author=L+Pewe&amp;author=S+Perlman&amp;volume=169&amp;publication_year=2006&amp;pages=209-222&amp;pmid=16816374&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Stohlman1">34. <span class="element-citation">Stohlman SA, Hinton DR, Parra B, Atkinson R, Bergmann CC. CD4 T cells contribute to virus control and pathology following CNS infection by neurotropic mouse hepatitis virus. <span><span class="ref-journal">J Virol </span>2007</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2258904/">PMC free article</a>]</span> [<a href="/pubmed/18094171" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=CD4+T+cells+contribute+to+virus+control+and+pathology+following+CNS+infection+by+neurotropic+mouse+hepatitis+virus.&amp;author=SA+Stohlman&amp;author=DR+Hinton&amp;author=B+Parra&amp;author=R+Atkinson&amp;author=CC+Bergmann&amp;publication_year=2007&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Pewe4">35. <span class="element-citation">Pewe LL, Netland JM, Heard SB, Perlman S. Very diverse CD8 T cell clonotypic responses after virus infections. <span><span class="ref-journal">J Immunol. </span>2004;<span class="ref-vol">172</span>:3151\xe2\x80\x933156.</span> [<a href="/pubmed/14978121" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Very+diverse+CD8+T+cell+clonotypic+responses+after+virus+infections.&amp;author=LL+Pewe&amp;author=JM+Netland&amp;author=SB+Heard&amp;author=S+Perlman&amp;volume=172&amp;publication_year=2004&amp;pages=3151-3156&amp;pmid=14978121&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Chen1">36. <span class="element-citation">Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, et al.  Structural and kinetic basis for heightened immunogenicity of T cell vaccines. <span><span class="ref-journal">J Exp Med. </span>2005;<span class="ref-vol">201</span>:1243\xe2\x80\x931255.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2213140/">PMC free article</a>]</span> [<a href="/pubmed/15837811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Structural+and+kinetic+basis+for+heightened+immunogenicity+of+T+cell+vaccines.&amp;author=JL+Chen&amp;author=G+Stewart-Jones&amp;author=G+Bossi&amp;author=NM+Lissin&amp;author=L+Wooldridge&amp;volume=201&amp;publication_year=2005&amp;pages=1243-1255&amp;pmid=15837811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-AlexanderMiller1">37. <span class="element-citation">Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1996;<span class="ref-vol">93</span>:4102\xe2\x80\x934107.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC39494/">PMC free article</a>]</span> [<a href="/pubmed/8633023" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Selective+expansion+of+high-+or+low-avidity+cytotoxic+T+lymphocytes+and+efficacy+for+adoptive+immunotherapy.&amp;author=MA+Alexander-Miller&amp;author=GR+Leggatt&amp;author=JA+Berzofsky&amp;volume=93&amp;publication_year=1996&amp;pages=4102-4107&amp;pmid=8633023&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Bullock1">38. <span class="element-citation">Bullock TN, Mullins DW, Engelhard VH. Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8(&#x0002b;) T cells. <span><span class="ref-journal">J Immunol. </span>2003;<span class="ref-vol">170</span>:1822\xe2\x80\x931829.</span> [<a href="/pubmed/12574347" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Antigen+density+presented+by+dendritic+cells+in+vivo+differentially+affects+the+number+and+avidity+of+primary,+memory,+and+recall+CD8(&#x0002b;)+T+cells.&amp;author=TN+Bullock&amp;author=DW+Mullins&amp;author=VH+Engelhard&amp;volume=170&amp;publication_year=2003&amp;pages=1822-1829&amp;pmid=12574347&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Rubio1">39. <span class="element-citation">Rubio V, Stuge TB, Singh N, Betts MR, Weber JS, et al.  Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. <span><span class="ref-journal">Nat Med. </span>2003;<span class="ref-vol">9</span>:1377\xe2\x80\x931382.</span> [<a href="/pubmed/14528297" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Ex+vivo+identification,+isolation+and+analysis+of+tumor-cytolytic+T+cells.&amp;author=V+Rubio&amp;author=TB+Stuge&amp;author=N+Singh&amp;author=MR+Betts&amp;author=JS+Weber&amp;volume=9&amp;publication_year=2003&amp;pages=1377-1382&amp;pmid=14528297&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Boon1">40. <span class="element-citation">Boon AC, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:6024\xe2\x80\x936032.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1472604/">PMC free article</a>]</span> [<a href="/pubmed/16731941" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=The+hypervariable+immunodominant+NP418-426+epitope+from+the+influenza+A+virus+nucleoprotein+is+recognized+by+cytotoxic+T+lymphocytes+with+high+functional+avidity.&amp;author=AC+Boon&amp;author=G+de+Mutsert&amp;author=RA+Fouchier&amp;author=AD+Osterhaus&amp;author=GF+Rimmelzwaan&amp;volume=80&amp;publication_year=2006&amp;pages=6024-6032&amp;pmid=16731941&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Lauer1">41. <span class="element-citation">Lauer GM, Ouchi K, Chung RT, Nguyen TN, Day CL, et al.  Comprehensive analysis of CD8(&#x0002b;)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. <span><span class="ref-journal">J Virol. </span>2002;<span class="ref-vol">76</span>:6104\xe2\x80\x936113.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC136241/">PMC free article</a>]</span> [<a href="/pubmed/12021343" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Comprehensive+analysis+of+CD8(&#x0002b;)-T-cell+responses+against+hepatitis+C+virus+reveals+multiple+unpredicted+specificities.&amp;author=GM+Lauer&amp;author=K+Ouchi&amp;author=RT+Chung&amp;author=TN+Nguyen&amp;author=CL+Day&amp;volume=76&amp;publication_year=2002&amp;pages=6104-6113&amp;pmid=12021343&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Leslie1">42. <span class="element-citation">Leslie A, Price DA, Mkhize P, Bishop K, Rathod A, et al.  Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. <span><span class="ref-journal">J Immunol. </span>2006;<span class="ref-vol">177</span>:4699\xe2\x80\x934708.</span> [<a href="/pubmed/16982909" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Differential+selection+pressure+exerted+on+HIV+by+CTL+targeting+identical+epitopes+but+restricted+by+distinct+HLA+alleles+from+the+same+HLA+supertype.&amp;author=A+Leslie&amp;author=DA+Price&amp;author=P+Mkhize&amp;author=K+Bishop&amp;author=A+Rathod&amp;volume=177&amp;publication_year=2006&amp;pages=4699-4708&amp;pmid=16982909&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Erickson1">43. <span class="element-citation">Erickson AL, Kimura Y, Igarashi S, Eichelberger J, Houghton M, et al.  The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. <span><span class="ref-journal">Immunity. </span>2001;<span class="ref-vol">15</span>:883\xe2\x80\x93895.</span> [<a href="/pubmed/11754811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=The+outcome+of+hepatitis+C+virus+infection+is+predicted+by+escape+mutations+in+epitopes+targeted+by+cytotoxic+T+lymphocytes.&amp;author=AL+Erickson&amp;author=Y+Kimura&amp;author=S+Igarashi&amp;author=J+Eichelberger&amp;author=M+Houghton&amp;volume=15&amp;publication_year=2001&amp;pages=883-895&amp;pmid=11754811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Moskophidis1">44. <span class="element-citation">Moskophidis D, Zinkernagel RM. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. <span><span class="ref-journal">J Virol. </span>1995;<span class="ref-vol">69</span>:2187\xe2\x80\x932193.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC188887/">PMC free article</a>]</span> [<a href="/pubmed/7533851" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Immunobiology+of+cytotoxic+T-cell+escape+mutants+of+lymphocytic+choriomeningitis+virus.&amp;author=D+Moskophidis&amp;author=RM+Zinkernagel&amp;volume=69&amp;publication_year=1995&amp;pages=2187-2193&amp;pmid=7533851&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Price1">45. <span class="element-citation">Price GE, Ou R, Jiang H, Huang L, Moskophidis D. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia. <span><span class="ref-journal">J Exp Med. </span>2000;<span class="ref-vol">191</span>:1853\xe2\x80\x931867.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2213532/">PMC free article</a>]</span> [<a href="/pubmed/10839802" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Viral+escape+by+selection+of+cytotoxic+T+cell-resistant+variants+in+influenza+A+virus+pneumonia.&amp;author=GE+Price&amp;author=R+Ou&amp;author=H+Jiang&amp;author=L+Huang&amp;author=D+Moskophidis&amp;volume=191&amp;publication_year=2000&amp;pages=1853-1867&amp;pmid=10839802&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Tester1">46. <span class="element-citation">Tester I, Smyk-Pearson S, Wang P, Wertheimer A, Yao E, et al.  Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. <span><span class="ref-journal">J Exp Med. </span>2005;<span class="ref-vol">201</span>:1725\xe2\x80\x931731.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2213272/">PMC free article</a>]</span> [<a href="/pubmed/15939788" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Immune+evasion+versus+recovery+after+acute+hepatitis+C+virus+infection+from+a+shared+source.&amp;author=I+Tester&amp;author=S+Smyk-Pearson&amp;author=P+Wang&amp;author=A+Wertheimer&amp;author=E+Yao&amp;volume=201&amp;publication_year=2005&amp;pages=1725-1731&amp;pmid=15939788&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Pircher1">47. <span class="element-citation">Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, et al.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. <span><span class="ref-journal">Nature. </span>1990;<span class="ref-vol">346</span>:629\xe2\x80\x93633.</span> [<a href="/pubmed/1696684" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Viral+escape+by+selection+of+cytotoxic+T+cell-resistant+virus+variants+in+vivo.&amp;author=H+Pircher&amp;author=D+Moskophidis&amp;author=U+Rohrer&amp;author=K+Burki&amp;author=H+Hengartner&amp;volume=346&amp;publication_year=1990&amp;pages=629-633&amp;pmid=1696684&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Kuo1">48. <span class="element-citation">Kuo L, Godeke GJ, Raamsman MJ, Masters PS, Rottier PJ. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. <span><span class="ref-journal">J Virol. </span>2000;<span class="ref-vol">74</span>:1393\xe2\x80\x931406.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC111474/">PMC free article</a>]</span> [<a href="/pubmed/10627550" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Retargeting+of+coronavirus+by+substitution+of+the+spike+glycoprotein+ectodomain:+crossing+the+host+cell+species+barrier.&amp;author=L+Kuo&amp;author=GJ+Godeke&amp;author=MJ+Raamsman&amp;author=PS+Masters&amp;author=PJ+Rottier&amp;volume=74&amp;publication_year=2000&amp;pages=1393-1406&amp;pmid=10627550&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Ontiveros1">49. <span class="element-citation">Ontiveros E, Kuo L, Masters PS, Perlman S. Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. <span><span class="ref-journal">Virology. </span>2001;<span class="ref-vol">289</span>:230\xe2\x80\x93238.</span> [<a href="/pubmed/11689046" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Inactivation+of+expression+of+gene+4+of+mouse+hepatitis+virus+strain+JHM+does+not+affect+virulence+in+the+murine+CNS.&amp;author=E+Ontiveros&amp;author=L+Kuo&amp;author=PS+Masters&amp;author=S+Perlman&amp;volume=289&amp;publication_year=2001&amp;pages=230-238&amp;pmid=11689046&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Ogino1">50. <span class="element-citation">Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, et al.  Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. <span><span class="ref-journal">J Mol Diagn. </span>2005;<span class="ref-vol">7</span>:413\xe2\x80\x93421.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1867544/">PMC free article</a>]</span> [<a href="/pubmed/16049314" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Diagn&amp;title=Sensitive+sequencing+method+for+KRAS+mutation+detection+by+Pyrosequencing.&amp;author=S+Ogino&amp;author=T+Kawasaki&amp;author=M+Brahmandam&amp;author=L+Yan&amp;author=M+Cantor&amp;volume=7&amp;publication_year=2005&amp;pages=413-421&amp;pmid=16049314&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Hamilton1">51. <span class="element-citation">Hamilton SE, Harty JT. Quantitation of CD8&#x0002b; T cell expansion, memory, and protective immunity after immunization with peptide-coated dendritic cells. <span><span class="ref-journal">J Immunol. </span>2002;<span class="ref-vol">169</span>:4936\xe2\x80\x934944.</span> [<a href="/pubmed/12391206" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Quantitation+of+CD8&#x0002b;+T+cell+expansion,+memory,+and+protective+immunity+after+immunization+with+peptide-coated+dendritic+cells.&amp;author=SE+Hamilton&amp;author=JT+Harty&amp;volume=169&amp;publication_year=2002&amp;pages=4936-4944&amp;pmid=12391206&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Leslie2">52. <span class="element-citation">Leslie AGW.  <span class="ref-journal">Recent changes to the MOSFLM package for processing film and image plate data. In Joint CCP4 &#x0002b; ESF-EAMCB Newsletter on Protein Crystallography.</span> Warrington: Daresbury Laboratory; 1992.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Recent+changes+to+the+MOSFLM+package+for+processing+film+and+image+plate+data.+In+Joint+CCP4+&#x0002b;+ESF-EAMCB+Newsletter+on+Protein+Crystallography&amp;author=AGW+Leslie&amp;publication_year=1992&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Evans1">53. <span class="element-citation">Evans PR.  Data reduction. In Proceedings of the CCP4 study weekend. Data collection and processing. In: Sawyer L, Isaacs NW, Bailey S, editors. Warrington: Daresbury Laboratory; 1993. pp. 114\xe2\x80\x93122. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Evans+PR+1993+Data+reduction.+In+Proceedings+of+the+CCP4+study+weekend.+Data+collection+and+processing.+Sawyer+L+Isaacs+NW+Bailey+S+Warrington+Daresbury+Laboratory+114+122+" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Storoni1">54. <span class="element-citation">Storoni LC, McCoy AJ, Read RJ. Likelihood-enhanced fast rotation functions. <span><span class="ref-journal">Acta Crystallogr D Biol Crystallogr. </span>2004;<span class="ref-vol">60</span>:432\xe2\x80\x93438.</span> [<a href="/pubmed/14993666" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallogr+D+Biol+Crystallogr&amp;title=Likelihood-enhanced+fast+rotation+functions.&amp;author=LC+Storoni&amp;author=AJ+McCoy&amp;author=RJ+Read&amp;volume=60&amp;publication_year=2004&amp;pages=432-438&amp;pmid=14993666&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Afonine1">55. <span class="element-citation">Afonine PV, Grosse-Kunstleve RW, Adams PD. A robust bulk-solvent correction and anisotropic scaling procedure. <span><span class="ref-journal">Acta Crystallographica Section D. </span>2005;<span class="ref-vol">61</span>:850\xe2\x80\x93855.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2808320/">PMC free article</a>]</span> [<a href="/pubmed/15983406" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallographica+Section+D&amp;title=A+robust+bulk-solvent+correction+and+anisotropic+scaling+procedure.&amp;author=PV+Afonine&amp;author=RW+Grosse-Kunstleve&amp;author=PD+Adams&amp;volume=61&amp;publication_year=2005&amp;pages=850-855&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Murshudov1">56. <span class="element-citation">Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. <span><span class="ref-journal">Acta Crystallogr D Biol Crystallogr. </span>1997;<span class="ref-vol">53</span>:240\xe2\x80\x93255.</span> [<a href="/pubmed/15299926" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallogr+D+Biol+Crystallogr&amp;title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method.&amp;author=GN+Murshudov&amp;author=AA+Vagin&amp;author=EJ+Dodson&amp;volume=53&amp;publication_year=1997&amp;pages=240-255&amp;pmid=15299926&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Emsley1">57. <span class="element-citation">Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. <span><span class="ref-journal">Acta Crystallogr D Biol Crystallogr. </span>2004;<span class="ref-vol">60</span>:2126\xe2\x80\x932132.</span> [<a href="/pubmed/15572765" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallogr+D+Biol+Crystallogr&amp;title=Coot:+model-building+tools+for+molecular+graphics.&amp;author=P+Emsley&amp;author=K+Cowtan&amp;volume=60&amp;publication_year=2004&amp;pages=2126-2132&amp;pmid=15572765&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Lamzin1">58. <span class="element-citation">Lamzin VS, Wilson KS. Automated refinement of protein models. <span><span class="ref-journal">Acta Crystallographica Section D. </span>1993;<span class="ref-vol">49</span>:129\xe2\x80\x93147.</span> [<a href="/pubmed/15299554" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Crystallographica+Section+D&amp;title=Automated+refinement+of+protein+models.&amp;author=VS+Lamzin&amp;author=KS+Wilson&amp;volume=49&amp;publication_year=1993&amp;pages=129-147&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ppat.1000186-Williams1">59. <span class="element-citation">Williams RK, Jiang GS, Holmes KV. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1991;<span class="ref-vol">88</span>:5533\xe2\x80\x935536.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC51911/">PMC free article</a>]</span> [<a href="/pubmed/1648219" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Receptor+for+mouse+hepatitis+virus+is+a+member+of+the+carcinoembryonic+antigen+family+of+glycoproteins.&amp;author=RK+Williams&amp;author=GS+Jiang&amp;author=KV+Holmes&amp;volume=88&amp;publication_year=1991&amp;pages=5533-5536&amp;pmid=1648219&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2563037&amp;issue-id=171924&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS Pathogens</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2563037/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2563037/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2563037/pdf/ppat.1000186.pdf">PDF (608K)</a></li> | <li><a href="#" data-citationid="PMC2563037" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2563037%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2563037%2F&amp;text=Prevention%20of%20Cytotoxic%20T%20Cell%20Escape%20Using%20a%20Heteroclitic%20Subdominant%20Viral%20T%20Cell%20Determinant"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2563037%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="18949029" data-aiid="2563037" data-aid="2563037" data-iid="171924" data-domainid="349" data-domain="plospath" data-accid="PMC2563037" data-md5="bf3f4a10a090f400b11ef7a0422a21a9"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:52:29-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A499BE99B05210000000002BE02BE&amp;ncbi_session=8A1A499BE99B49C1_0702SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2563037%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plospath&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2563037/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A499BE99B49C1_0702SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'